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ABSTRACT
DISSECTING THE HISTONE-BINDING MECHANISM OF A PHD FINGER
SUBTYPE
DANIEL BOAMAH
2017
Disordered tails of histones are critical information retrieval hub and thus,
aberrations in the flow of information through these hubs are associated with a number of
pathological consequences in human. Mechanism for retrieval of information from these
hubs is achieved by protein-protein interaction, i.e. proteins dock onto histone tails to
initiate chromatin signaling. Eukaryotes have a number of small peptide binding domains
that have evolved to specifically interact with histone tails, and these domains called
histone readers as they read the information encoded on histone tails. Plant
homeodomain (hereafter PHD) finger, a binucleated zinc finger, family is one such
histone readers. Next-generation sequencing efforts on diagnosed patient’s genomes or
cancer tissues show that mutations in PHD finger, particularly a subgroup of PHD
fingers, are associated with number of pathological consequences. Therefore, for future
understanding of the possible mechanisms for the pathological consequences, as an initial
step, detailed characterization of the binding mechanism of the PHD subtype, the
PHD_nW_DD, was undertaken here. Starting with human BAZ2A (bromodomain
adjacent to zinc-finger 2A), one member of the PHD_nW_DD subtype that is associated
with prostate cancer was utilized to probe the effect of mutations on histone tail binding.
We experimentally discovered two categories of mutations that disrupt peptide
binding: (1) Type-A: positions that are in contact with the peptide and (2) Type-B:
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positions that are remote from the peptide-binding site (distal site). For my dissertation, I
focused on understanding the biochemical basis of the effects of Type-A mutations using
recombinant protein chemistry and biophysical chemistry.
The peptide-anchoring residue positions of BAZ2A-PHD, interestingly, are
enriched in specific type of residues in a subtype specific manner. The energetics
revealed that, two non-polar amino acid residues and an Aspartate residue in the treble
clef knuckle make significant contributions to the formation of the hBAZ2A-histone
peptide complex as mutations at these three positions completely aborted peptide binding.
The energetic contributions of the identified positions were further confirmed by
mutagenesis in three members of the subtype (UHRF1-PHD, KDM5B-PHD and
KAT6A-PHD) that included pairs sharing even less than 40% sequence identity with
each other. Despite low sequence similarity, mutations cause similar consequences in
histone H3 binding suggesting a strong similarity in the binding mechanism, and thus
justifying the subtype classification.

1
CHAPTER I
INTRODUCTION
1.1. General Introduction
Structure dictates functions, and thus, the protein fold (the precise arrangement of
the secondary structures in space) is intricately related to the function a protein performs.
A protein fold is often also associated with a large sequence space meaning that several
different sequences including diverse ones, that retain a few common sequence features,
can adopt the same structural fold1-3. However, the precise biochemical function of
diverse sequences, despite retaining the same overall fold can significantly differ from
one another. Many protein folds are referred to as superfamilies for the diverse sequences
they contain and the diverse biochemical functions they perform.
Plant HomeoDomain (PHD), a binucleated Zn finger4-6, is one such superfamily
where the median sequence identity (in 85% non-redundant set)7 is only ~27%, i.e.
diverse sequences populate the PHD fold. Although the primary biochemical function of
PHD finger is to bind histone peptides, they can recognize different histone peptides. A
correlation between the sequences of the histone peptide and sequences of PHD finger
has been noted earlier7, 8 meaning that there are different subtypes of sequences within
the PHD superfamily with each subtype capable of recognizing a distinct histone
sequence. Thus, correlating the energetic contributions of the binding-site residues of
PHD subtypes in the sequence specific interactions with histone peptides would be
valuable for sequence-based classification of PHD fingers. The classification will be very
useful in the genome-wide functional annotation of PHD finger sequences. In addition,
detailed information of the energetic contributions of PHD residues will be useful for
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manipulating the binding behavior of PHD by residue substitution, and this in turn can be
useful for manipulating gene regulatory mechanisms, and then enable probing pathway
specific flow of epigenetic information.
For this dissertation, we thus focus on PHD, particularly a specific subtype of the
PHD finger. In general, PHD finger contains approximately 50-80 amino acid residue4-6
with a characteristic cross-braced topology having two zinc atoms coordinated by one
Histidine and seven cysteine residues within a Cys4-His-Cys3 sequence motif8 (Figure
1.1)7, 9. PHD finger was discovered in the protein HAT3.1 in Arabidopsis thaliana in
19936, 10. Most of the proteins with PHD fingers are found in the nucleus11, 12 because
they are mainly involved in the modification of chromatin as well as the mediation of
molecular interactions in gene transcription6, 8, 11, 13. They may occur as a single finger but
can often be seen in cluster of two (Figure 1.2)7, 9 or more, and can also occur in tandem
with other domains, such as bromodomain and chromodomain6, 8, 12, 14.
Earlier discovery of their function in chromatin regulation showed that they bind
methylated-lysine histone H314-17. However, recent studies have shown them to have a
sophisticated ability to recognize other sequences of histones, including histone peptides
lacking post-translational modification (e.g., unmodified histones)7, 8, 18, 19. These studies
reinforce that they are versatile in their ability to recognize histone sequences (modified
and unmodified) in their role as epigenome readers that control gene expression by
recruiting transcription factors and chromatin regulators7-9, 18, 19.
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Figure 1.1. A topological diagram of the PHD fold: The Cys and His residues hold the binucleated Zn
atoms. A subtype that we study here has two Aspartate residues in the treble clef knuckle. The pair of Asp
residues is noted to anchor the Arg2 of Histone H3 peptide.

The Zn-chelating Cys and His residues in many Zn-fingers (e.g., PHD finger,
RING finger, FYVE finger etc.) appear with a characteristic 3D pattern called treble clef.
The treble clef 3D motif 20 refers to a combination of a knuckle and a helix (Figure 1.1).
In the treble clef motif, the knuckle provides two cysteine residues and the N-terminal of
the helix provides the other two Zn-chelating cysteine residues for chelating the Zn atom.
Many domains or folds contain treble cleft motif and PHD finger is one of them.
Many of these domains or folds (e.g., PHD finger, RING finger, FYVE finger etc.), in
addition to possessing the treble clef motif, can have other secondary structural element
that distinguish them from one another. For the discussion of this dissertation we often
refer to treble cleft portion of the PHD finger and our entire study is about PHD finger
(and not any other treble clef containing domains or folds).
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Figure 1.2. Alignment of tandem PHD-PHD sequences as reported in Chakravarty et al., 2015. The zinc
chelating positions are shown in green, red bar shows the presence of Aspartate residues and the gray bar
shows the absence of Aspartate residues.

The treble clef portion of some of the PHD fingers have been reported to possess a
pair of Asp residues7 that can interact with the Arg2 of the Histone H3 peptide. This
characteristic pattern of Aspartic acid residue within the treble clef knuckle has been
shown to be a subtype-specific property7 and the pair of Asp residues make a significant
energetic contribution to the formation of the protein-peptide complex7. However, it is
not clear if the presence of the treble clef Asp residues in the PHD sequences is enough
for histone peptide binding. It is likely that other amino acid residues in the PHD
sequence also make large contributions to the energetics of the protein-peptide complex
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formation. In this, I wanted to identify the characteristics of those residues that make
large energetic contributions for anchoring the H3 peptide. In addition, I wanted to
determine if there are residues remote from the binding site that also contribute to peptide
binding as this provides an opportunity to modulate binding by manipulations without
altering the binding site. For this dissertation, therefore, I discuss histone-binding
mechanism of PHD finger subtype in the context of energetic contributions of PHD
subtype specific residues.

1.2. Introduction to research
Protein-protein interaction on the chromosomes decisively contributes to the
interpretation of the information encoded in the genome, and the tethering of proteins
onto the intrinsically disordered tails of histones is a critical component of the
chromosomal protein-protein interactions. Regulatory protein complexes, bound onto
histone tails, are known to orchestrate chromatin-signaling pathways, which collectively
regulate chromatin structure and thereby exert ultimate control over all the diverse
biological outcomes associated with chromatin21, 22. Eukaryotes have evolved peptideanchoring scaffolds (typically called readers)23 to specifically recognize histone peptide
segments24-27. In general, the disordered peptide segments of histone tails provide the
binding surface for readers (present within the regulatory protein complexes) to facilitate
the anchorage of regulatory complexes onto the chromatin.
Over the past decade, fascinating discoveries on the mechanisms of histone peptide
recognition, revealed by high-resolution structures of readers in complex with cognate
peptides24-27 are helping us to understand chromatin regulatory mechanisms in much
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greater detail. For example, structures of histone recognition are providing important
starting points to further probe detailed pathway-specific molecular mechanisms (e.g.
Reengineering readers to switch their specificity for probing and altering DNA
methylation landscapes in living stem cells)28, 29.
Opposed to de novo design, reader reengineering involves manipulation of a few
binding site residues of an existing reader leaving the rest of the reader sequence
unaltered28, 29. Therefore, structure guided dissection of the key determinants of histone
peptide recognition mechanisms will continue to play important role not just in probing
chromatin-signaling mechanisms but also in the design of reagents for diagnostic
applications30, 31. Motivated by the application outcomes, our lab had earlier probed the
energetics of the recognition of histone H3 N-terminal peptide by readers belonging to
the same structural scaffold, the plant homeodomain (PHD)-finger, that recognize the
same peptide sequence7.
The study revealed that recognition mechanisms could differ in the readout of the
same peptide sequence by readers of even the same scaffold. It was also noted that the
energetic contributions of the peptide amino acids correlated with the sequence features
of the readers. For example, H3 Lys4 makes negligibly small energetic contributions
towards N-terminal H3 recognition by PHD readers featuring a treble clef xCDxCDx
motif, while H3 Lys4 makes a substantial energetic contribution for readers lacking the
motif7. This lead to speculate that subtype specific sequence patterns for readers evolved
for distinctly interacting with even the same peptide sequence, and a comprehension of
the roles of all subtype specific sequence features would be invaluable to manipulate a
reader’s substrate preferences for the above applications. Therefore, here, we investigate
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the contributions of the subtype specific features of readers using the treble clef
xCDxCDx motif featuring PHD subtype as a model to better understand histoneanchoring adaptations.
PHD-finger of BAZ2A (bromodomain adjacent to zinc finger domain protein 2A),
one of the xCDxCDx motif featuring readers was chosen as the base member for a
detailed investigation of the peptide anchoring mechanism for the following reasons.
BAZ2A, a subunit of the chromatin remodeling complex NoRC (nucleolar remodeling
complex)32, possesses the PHD-Bromodomain cassette for facilitating chromatin
anchorage of NoRC33, 34 for rDNA silencing35, 36. Likely for its critical role, BAZ2A
overexpression is tightly associated with prostate cancer 37, where BAZ2A, along with
EZH2 (enhancer of zeste homolog 2), coordinates epigenetic silencing in prostate cancer
cells37. Thus, the possibility of therapeutically targeting BAZ2A chromatin anchoring
scaffold has also been suggested37, and we, therefore, dissect the binding characteristics
of BAZ2A-PHD.
The recent structure of the BAZ2A-PHD in complex with histone H3 N-terminal
peptide highlights the role of acidic patch, another subtype specific feature, in peptide
recognition38, suggesting the importance of recognizable sequence features in the
functional characterization of readers. This work thus complements the structural report
as we investigate a number of other sequences features, in addition to the acidic patch,
not only in BAZ2A but also in several other readers. Initiated with BAZ2A-PHD, we
follow up the probing of position specific contributions of residues using four additional
readers (sharing low sequence similarity with BAZ2A-PHD). Based on an experimental
analysis of a set consisting of a total of 29 proteins (5 wild type readers and their 24
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mutants), we provide a comprehensive view of histone peptide recognition by a reader
subtype.
The versatile canonical PHD binding-site8, like the versatile PDZ domain bindingsite39, 40, binds terminal peptides (e.g., the N-terminal H3) predominantly by beta
augmentation41, and therefore , comparison of the binding mechanisms between the two
is natural. The extensive work on PDZ binding mechanisms probed by large-scale
mutagenesis40, sequence randomization42, and proteomic scale binding analysis43, 44 have
been complemented by computational studies to extract correlation between PDZ
binding-site positions45 for an evolutionary view on the origin of PDZ subtypes and
binding versatility. Although the number of mutations considered in this study is
comparatively much smaller than the hundreds of mutations used in the PDZ40 binding
mechanism study, the results obtained using a reasonable size of the PHD proteins
studied here, encouraged us to similarly probe the relationship between PHD binding-site
positions by computational approaches here for a view on nature’s design principles of
versatile binding-sites. In addition, the experimental binding thermodynamics observed
here also encourages us to computationally analyze natural adaptations for anchoring
histone tails, as these peptides lack the common peptide hotspot residues (W, Y, F, L and
I)46. Overall, we provide a case-specific study of histone-reader interactions in the
context of: (a) superfamily subtype characterization, (b) evolutionary relationship
between positions of versatile binding-sites and (c) general adaptations for anchoring
onto unmodified histone tails.
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CHAPTER II
ENERGETICS OF THE INTERACTIONS BETWEEN HUMAN BAZ2A-PHD
FINGER-HISTONE H3
ABSTRACT
PHD-finger of BAZ2A (bromodomain adjacent to zinc-finger 2A) protein is a
histone H3 N-terminal peptide reader that uses the treble clef xCDxCDx motif for the
recognition of the peptide. It is overexpressed in prostate cancer. The possibility of
therapeutically targeting BAZ2A chromatin-anchoring scaffold for the metastatic
potential of prostate cancer has recently been suggested37. Though some work has been
done on the molecular mechanism as to how this protein interacts with the histone H3,
the energetics involved in the interaction is lacking. As an initial step for the
understanding of the possible mechanisms and the energetics, detailed characterization of
the binding mechanism of the BAZ2A-PHD was undertaken.
Here, we have performed systematic site-specific mutagenesis in the recombinant
version of this PHD finger, purified mutant proteins and measured interaction affinity
between the mutant proteins and histone H3 using ITC (Isothermal Titration
Calorimetry). We show that, two categories of mutations disrupt peptide binding: (1)
Type-A: positions that are in contact with the peptide and (2) Type-B: positions that are
remote from the peptide-binding site (distal site). For this dissertation, we focused on
understanding the biochemical basis of the effects of Type-A mutations.
The peptide-anchoring residue positions of BAZ2A-PHD making large energetic
contributions are enriched in specific amino acids (bulky non-polar and acidic). The
bulky non-polar amino acid residues identified here are Leu-1692 and Leu-1693 and are
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tightly packed with the small side chains of the histone peptide. An Aspartate residue in
the treble clef knuckle, Asp 1695, also makes significant energetic contribution to the
formation of the hBAZ2A-histone peptide complex. Ala substitutions at these positions
mentioned above completely aborted peptide binding.
The recognition features identified here could be exploited in the PHD-finger subtype
possessing the same scaffold and possibly utilized to develop peptide diagnostics for
epigenome.

INTRODUCTION
The human Bromodomain Adjacent to Zinc finger 2A (BAZ2A) also called TIP5,
is a part of the chromatin remodeling complex NoRC (nucleolar remodeling complex)
known to be involved in epigenetic rRNA gene silencing37, 47. BAZ2A regulates
numerous protein-coding genes and directly interacts with EZH2 to maintain epigenetic
silencing at genes repressed in metastasis37. BAZ2A is a very large multidomain protein
of a molecular weight of 211kDa and consists of a number of DNA and protein
interaction domains33, 47. The protein contains a DNA binding homeobox and different
transcription factors, methyl-CpG-binding domain, AT-hook DNA –binding domains,
and a PHD (plant homeodomain) zinc finger adjacent to a bromodomain at their C
terminus47(Figure 2.1). The PHD zinc finger adjacent to the bromodomain has been
shown to have a significant role in the NoRC function, binding to HDAC1 (histone
deacetylase 1) DNMTs (DNA methyltransferases), and ATPase subunit SNF2h36. It has
also been shown to belong to a PHD zinc finger family proteins that harbor
PHD_nW_DD subtype7. Through next-generation sequencing efforts on diagnosed
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patients’ genomes or cancer tissues, it has come to light that aberrations (mutations,
overexpression) in proteins harboring PHD_nW_DD subtype are associated with
different pathological consequences37, 48-53(Figure 4.1). For example, mutations in MLL2
PHD has been reported to result in different types of cancers54-60. BAZ1A and MLL3
have also been reported in rare tumors of gynaecological origin61.Therefore for future
comprehension of the mechanisms for pathological consequences, as a first step, detailed
characterization of the binding mechanism of the PHD_nW_DD was undertaken here,
starting with one member (BAZ2A-PHD) of the subtype.
Systematic site-specific mutagenesis in the recombinant version of this BAZ2APHD was performed, purified mutant proteins and measured interaction affinity between
the mutant proteins and histone H3 using ITC (Isothermal Titration Calorimetry) to infer
the molecular basis of the spatial connectivity or coupling between binding site amino
acids and those away from the functional site.

Figure 2.1. Domain organization of human BAZ2A containing PHD zinc finger adjacent to bromodomain:
The MBD (methyl-CpG-binding domain) is the first domain, followed by the DDT (DNA binding
homeobox and different transcription factors) domain, the PHD zinc finger is colored indigo which is
adjacent to the bromodomain.
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MATERIALS AND METHODS
DNA constructs
The recombinant BAZ2A-PHD finger (residues 1673-1728 UniProt ID
Q9UIF9/BAZ2A_HUMAN) used here was taken from an earlier work in the lab7.
Briefly, BAZ2A-PHD was originally cloned into pETite N-His SUMO Kanamycin
expression vector. 14 BAZ2A-PHD mutants (see mutant list in Table 2.8) were created
using site directed mutagenesis. DNA sequences of wild type and all mutants were
confirmed by DNA sequencing (Genscript). In total, 15 proteins (1 wild type and 14
mutants) created in this study are used to probe the peptide binding mechanisms of PHD
finger subtype (BAZ2A).

Molecular Cloning
Synthetic DNA molecule of hBAZ2A-PHD of UniProt ID
Q9UIF9/BAZ2A_HUMAN, residues 1673-1728 was obtained from GenScript and PCR
(polymerase chain reaction) amplified using Thermo Scientific Phusion High Fidelity
DNA Polymerase. It was sub-cloned into pETite N-His SUMO Kanamycin expression
vector (Lucigen). This was a ligation independent (enzyme-free) cloning and expression
system in which the gene of interest was cloned under the control of the L-rhamnoseinducible rhaPBAD promoter harbored on one of the pRhamTM vectors62, 63, which replaces
the T7 promoter. The synthetic BAZ2A was PCR amplified with primers that contained
short homology to the ends of the pETite N-His SUMO Kan vector (18 nucleotides of
overlap with the ends of the vector)62-65. The PCR product was then mixed with the preprocessed vector in a 1:1 ratio and transformed directly into the high-efficiency
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chemically competent cells (E. cloni® 10G SOLOs Chemically Competent Cells,
Lucigen). It was incubated overnight at 37°C for about 14 hours on kanamycin LB plate
(see transformation). Colony PCR was done to confirm clones, and individual colonies
were picked, cultured overnight at 37°C (for about 18 hours on kanamycin LB media).
The recombinant DNA (pETite_BAZ2A) was isolated using QIAprep spin miniprep kit
(QIAGEN). Agarose gel electrophoresis was run to confirm the presence and size of the
miniprep sample before they were sent to GenScript for DNA sequencing.
After DNA sequence was verified, plasmid was transformed into HI-Control® BL21
(DE3) SOLOs Chemically Competent cells (see transformation), protein expression was
done and purified for the biophysical measurements with the ITC. Fourteen mutations
were made in pETite_BAZ2A to change the amino acid residue positions to Alanine with
Site-Directed Mutagenesis. They were then expressed and purified for ITC
measurements.
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Figure 2.2. The cloning design strategy of pETite_BAZ2A-PHD using the enzyme-free technology by
Lucigen Simplifying genomics, where both forward and reverse primers are designed with 18 nucleotide
sequences overlapping that of the pETite N-His SUMO Kan vector.
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Table 2.1. The nucleotide and translated protein sequence of hBAZ2A for the cloning. The red colored
portion of the primer sequence represents the short homology to the ends of the pETite N-His SUMO Kan
vector (18 nucleotides of overlap with the ends of the vector).

Nucleotide Sequence
hBAZ2A-PHD

Primers

TCTGTCAACAAAGTGACATGTCTAGTCTGCCGGAAG
GGTGACAATGATGAGTTTCTTCTGCTTTGTGATGGG
TGTGACCGTGGCTGCCACATTTACTGCCATCGTCCC
AAGATGGAGGCTGTCCCAGAAGGAGATTGGTTCTG
TACTGTCTGTTTGGCTCAGCAGGTG
Protein Sequence
SVNKVTCLVCRKGDNDEFLLLCDGCDR
GCHIYCHRPKMEAVPEGDWFCTVCLA
QQV
Primer Sequence

Forward Primer (5’ to CATCATCACCACCATCACTCTGTCAACAAAGTGACA
TGT
3’)
Reverse Primer (5’to 3’) GTGGCGGCCGCTCTATTACACCTGCTGAGCCAAACA
GAC

Table 2.2. Reagents for PCR: The reaction was set up on ice and the reagents were added in the order they
appear in the table.

Component

Volume in 50µL Reaction/µL

Distilled water

35.5

5X Phusion buffer

10

10mM dNTPs

1

Forward Primer

1

Reverse Primer

1

16
Template DNA

1

Phusion DNA Polymerase

0.5

Table 2.3. PCR reaction cycle: The entire reaction took about 2 hours

Cycle step

Temperature

Time

Cycles

Initial Denaturation

98 °C

30sec

1

Denaturation

98 °C

10sec

Annealing

62 °C

30sec

Extension

72 °C

1min30sec

Final Extension

72 °C

10min

Final Hold

4 °C

∞

30

1

Transformation
These steps were applicable to E. coli DH5α, BL21 cells or any other E. coli cells
used for the cloning. The materials needed were 42 °C water bath, Ice, LB Plates with
appropriate antibiotics (kanamycin for hBAZ2A-PHD), Sterile SOC or LB (no
antibiotics)
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Procedure
•

DH5α or BL21 competent cells from -80 °C freezer was put on ice for 30min. The
competent cells were usually in eppendorf tube

•

Cells were gently mixed with the pipet tip (was not pipet up and down) and 30µL
was aliquot into 1.5ml eppendorf tube that had been pre-chilled on ice.

•

1µL of DNA was added to the cells and mixed gently

•

The tube was then incubated on ice for 30 minutes.

•

The SOC was Pre-warmed at 42°C

•

The cells were heat shocked for 45 seconds in a 42°C water bath without shaking.

•

The tube was then placed on ice for 2 minutes.

•

250µL of SOC was added to the cells and incubated at 37°C for 1 hour at 225rpm.

•

The Kanamycin agar plate was pre-warmed in the incubator at 37°C.

•

100µL of cells was inoculated and incubated at 37°C for overnight (12-16hours).

Protein Expression and Solubility Test
The recombinant hBAZ2A-PHD was transformed into HI-Control® BL21 (DE3)
SOLOs Chemically Competent cells (Lucigen) after the sequence was verified from
GenScript. Three separate colonies on the Kanamycin agar plate were selected for a
small-scale protein expression and solubility testing. This was done by inoculating them
in a 4ml LB/kanamycin media and incubated at 225rpm, 37°C till the optical density at
600nm (OD600) of each of the culture was between 0.2-0.4 (This was usually reached in
4hours). Half of the volume of each culture (2ml) was transferred into a new eppendorf
tube and induced with 1mM isopropyl β-D-1-thiogalactopyranoside (IPTG). They were
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then allowed to grow for another 3hours at the same conditions as above. The rest of the
test was carried out by the procedure below:
•

The cell cultures were pelleted in pre-weighed eppendorf tubes by centrifuging at
13000rpm for 10mins

•

0.5g of the pelleted cells were completely resuspended in a 1ml solution of 1x bug
buster.

•

The suspension was incubated on a shaker at 4°C for 20mins and then centrifuged
at 13000rpm for 10mins.

•

The supernatant, which now contains the soluble protein, was separated from the
pellet and SDS-PAGE gel run to determine the solubility of the protein

•

The remaining pellet (both induced and uninduced) was also used to run SDSPAGE gel to determine the expression of each colony picked.

A
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B

Figure 2.3. (A) SDS-PAGE gel of hBAZ2A-PHD Solubility test showing that the protein is soluble hence
can be seen in the supernatant with the size of 18.4KDa. Lane 2, which is the pellet, does not show such a
band, which means the protein, is clearly not in the pellet hence it is a soluble protein.
(B) SDS-PAGE gel of the expression test of 3 colonies of hBAZ2A-PHD. Lanes 1, 3 and 5 represents the
uninduced colonies. Lanes 2, 3 and 6 represents the colonies induced with 1mM IPTG. It can clearly be
seen that the induced colonies have bands at the 18.4KDa mark whereas the uninduced do not have that
band in the gel. Lane 7 represents the protein ladder that was used to determine the size of the protein.
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Protein Expression and Purification
After it was determined that the recombinant protein was soluble and could be
expressed, a 4litre culture was prepared by growing 30ml culture in an LB/kanamycin
media overnight at 37°C, 225rpm. The overnight grown culture was transferred to an
autoclaved terrific broth/kanamycin media and allowed to grow in a 37°C incubator at the
same rotation speed as above till the OD600 was between 0.6 and 1. The culture was then
induced with 1mM IPTG and transferred to a 16°C shaker (N-Biotek) at rotating speed of
225rpm and allowed to grow overnight (approximately 18hrs). The protein was isolated
and purified by His-tag affinity chromatography.
The overexpressed cells were lysed in a phosphate buffer (25mM phosphate buffer,
300mM NaCl at pH 7.6) with 10mg/ml of lysozyme, which facilitates in breaking the cell
wall of the bacteria to release the soluble protein in the buffer and 0.1mg/ml of IGEPALCA 600 (a nonionic, non-denaturing detergent which prevents surface-induced protein
aggregation in the buffer). The number of bacteria cells in the resuspension phosphate
buffer should be 30%. The resuspension was allowed to stand on ice for 30minutes
before it was treated with a Misonix ultrasonic liquid processor (Sonicator S-4000) for 5
minutes that further lysed the cells. The lysates were cleared by centrifugation (18000rpm
for 30min at 4°C, Beckman J2-MI centrifuge). After centrifugation, the supernatant that
contained the soluble protein was loaded on a phosphate buffer equilibrated nickel
sepharose high performance bead (GE Healthcare Life Sciences) overnight. The protein
was then eluted with an imidazole (200-250mM) solution at pH 7.6. It was finally
polished or purified to homogeneity by size exclusion gel filtration chromatography using
a HiLoad 26/600 superdex column using AKTA prime FPLC (GE Healthcare Life
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Sciences). The phosphate buffer at this step had 150mM NaCl. The peak corresponding
to the size of the protein was concentrated to the desired volume and concentration
determined by UV-Vis Nanodrop Spectrophotometer and Bradford Method. The purity of
the protein was confirmed by SDS-PAGE (Bio-Rad).
It must be stated that different conditions at the elution step (in terms of the amount
of salt in the buffer, the concentration of imidazole needed for the elution of the protein)
were tried in order to arrive at the optimized condition used for the purification (Figure
2.3 and 2.4).
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300mM Salt

250mM Salt

150mM Salt

Figure 2.4. FPLC profile with different NaCl salt concentrations in 25mM phosphate buffer to determine the optimum salt concentration needed for the elution
of BAZ2A-PHD. The Y-axis is the absorbance in mAu and the X-axis is the volume in ml. The various concentrations of the salt were used at the elution step
before loading the protein into the AKTA prime FPLC
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250-300mM Imidazole

150-200mM Imidazole

50-100mM Imidazole

Figure 2.5. FPLC profile with different imidazole concentrations in 25mM phosphate buffer to determine the range of imidazole concentration required for the
elution of BAZ2A-PHD. The Y-axis is the absorbance in mAu and the X-axis is the volume in ml. The various concentrations of the imidazole were used at the
elution step before loading the protein into the AKTA prime FPLC
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Figure 2.6. (A) SDS-PAGE gel of hBAZ2A-PHD purification process. The concentrated peak was
reloaded on the AKTA prime to get a much more purer protein as seen at B (B) FPLC profile of purified
hBAZ2A-PHD in 25mM phosphate buffer, 150mM NaCl, pH of 7.6, and the SDS-PAGE gel representing
the peak.

Determination of Protein Concentration by Bradford Method
Table 2.4. Absorbance measurements and concentration of Bovine Serum Albumin (BSA) used for the
Bradford standard curve

Tubes

Absorbance
1

Absorbance
2

Absorbance
3

Average
Absorbance
at 595nm

Concentration
(mg/ml)

1.347
1.278
1.118
0.953
0.8
0.616
0.509
0.366

1.373
1.254
1.117
0.938
0.792
0.602
0.494
0.386

1.37
1.251
1.112
0.948
0.791
0.606
0.476
0.362

1.36
1.26
1.12
0.95
0.79
0.61
0.49
0.37

2
1.5
1
0.75
0.5
0.25
0.125
0

1
2
3
4
5
6
7
8

Absorbance at 595nm

Standard curve obtained from Bradford
Assay
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0

y = 0.5016x + 0.4851
R² = 0.93597

0

0.5

1

1.5

2

2.5

Concentration (mg/ml)
Figure 2.7. Standard curve used for the determination of the protein concentration. It was performed from
the Quick Start Bradford Protein Assay protocol where 250µL of the Bradford solution and 5µL of each of
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the dilutions made from the standard BSA were used for the absorbance measurements. The equation of the
curve was used for the estimation of the protein concentration.

Mutagenesis
Fourteen mutants were made from the hBAZ2A-PHD to change the amino acid
residue positions to Alanine with Site-Directed Mutagenesis. hBAZ2A-PHD residues
that undergo a change in the accessible surface area with the peptide, ΔASASC, ≥ 10Å2 of
the side chain atoms were considered. Distal amino acid residues as well as aspartates in
the PHD treble-clef knuckle were also considered for the mutagenesis. Another factor
that was also taken into consideration in selecting which amino acid residue to mutate
was the distal negatively charged amino acid residues since histone H3 peptide is
positively charged hence it was expected that, electrostatics could contribute to the
binding.
Primers were designed and ordered from Integrated DNA Technologies (IDT) and
Site Directed Mutagenesis performed (Table 2.5 and Table 2.7). Most of the mutants
were obtained by using gradient PCR, where varying annealing temperatures were
employed to get the mutations to work.

Table 2.5. Mutagenesis reaction cycle: The entire reaction took about 1hour 45minutes

Cycle step

Temperature

Time

Cycles

Initial Denaturation

98 °C

30sec

1

Denaturation

98 °C

10sec

Annealing

Varying

30sec

18
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Extension

72 °C

1min30sec

Final Extension

72 °C

10min

Final Hold

4 °C

∞

1

Table 2.6. Reagents for Mutagenesis: The reaction was set up on ice and the reagents were added in the
order they appear in the table.

Component

Volume in 50µL Reaction/µL

Distilled water

35.5

5X Phusion buffer

10

10mM dNTPs

1

Forward Primer

1

Reverse Primer

1

Template DNA

1

(pETite_BAZ2A-PHD)
Phusion DNA Polymerase

0.5

Table 2.7. Primers used for the Site Directed Mutagenesis of hBAZ2A-PHD. The letter colored red is the
site of mutation

Mutant

Forward Primer (5’- Reverse Primer (5’-3’) Protein Sequence
3’)

V1674A CAGATTGGAGGT
TCTGCCAACAAA
GTGACCTGC

GCAGGTCACTT
TGTTGGCAGAA
CCTCCAATCTG

AHREQIGGSANK
VTCLVCRKGDND
EFLLLCDGCDRGC
HIYCHRPKMEAVPE
GDWFCTVCLAQQV

28
D1688A CGGAAGGGTGAC
AATGCTGAGTTT
CTTCTGCTT

AAGCAGAAGAA
ACTCAGCATTGT
CACCCTTCCG

E1689A

AAGGGTGACA
ATGATGCGTTT
CTTCTGCTTTGT

ACAAAGCAGAA
GAAACGCATCA
TTGTCACCCTT

L1692A

ACAATGATGAG
TTTCTTGCGCTTT
GTGATGGGTGTGA

TCACACCCATCA
CAAAGCGCAAGA
AACTCATCATTGT

L1693A

ATGATGAGTTTC
TTCTGGCTTGTGA
TGGGTGTGACCG

CGGTCACACCCA
TCACAAGCCAGA
AGAAACTCATCAT

D1695A TTTCTTCTGCTT
TGTGCTGGGTGT
GACCGTGGC

GCCACGGTCACA
CCCAGCACAAAG
CAGAAGAAA

D1698A CTTTGTGATGGG
TGTGCCCGTGGC
TGCCACATT

AATGTGGCAGCC
ACGGGCACACCC
ATCACAAAG

V1713A CCCAAGATGGA
GGCTGCCCCAGA
AGGAGATTGG

CCAATCTCCTT
CTGGGGCAGCC
TCCATCTTGGG

E1711A

CATCGTCCCAA
GATGGCGGCTG
TCCCAGAAGGA

TCCTTCTGGGA
CAGCCGCCATCT
TGGGACGATG

E1715A

ATGGAGGCTGTC
CCAGCAGGAGAT
TGGTTCTGT

ACAGAACCAAT
CTCCTGCTGGGA
CAGCCTCCAT

V1728A GTCTGTTTGGCTC
GTGGCGGCCGCTC
AGCAGGCGTAAT
TATTACGCCTGCT
AGAGCGGCCGCCAC GAGCCAAACAGAC
D1686A GTCTGCCGGAAG
GGTGCCAATGAT
GAGTTTCTT

AAGAAACTCATC
ATTGGCACCCTTC
CGGCAGAC

SVNKVTCLVCRKG
DNAEFLLLCDGCDR
GCHIYCHRPKMEAV
PEGDWFCTVCLAQQV
SVNKVTCLVCRKG
DNDAFLLLCDGCDR
GCHIYCHRPKMEAV
PEGDWFCTVCLAQQV
SVNKVTCLVCRKG
DNDEFLALCDGCDR
GCHIYCHRPKMEAV
PEGDWFCTVCLAQQV
SVNKVTCLVCRKG
DNDEFLLACDGCDR
GCHIYCHRPKMEAV
PEGDWFCTVCLAQQV
SVNKVTCLVCRKG
DNDEFLLLCAGCDR
GCHIYCHRPKMEAV
PEGDWFCTVCLAQQV
SVNKVTCLVCRKG
DNDEFLLLCDGCAR
GCHIYCHRPKMEAV
PEGDWFCTVCLAQQV
SVNKVTCLVCRKG
DNDEFLLLCDGCDR
GCHIYCHRPKMEAA
PEGDWFCTVCLAQQV
SVNKVTCLVCRKG
DNDEFLLLCDGCDR
GCHIYCHRPKMAAV
PEGDWFCTVCLAQQV
SVNKVTCLVCRKG
DNDEFLLLCDGCDR
GCHIYCHRPKMEAV
PAGDWFCTVCLAQQV
SVNKVTCLVCRKG
DNDEFLLLCDGCDR
GCHIYCHRPKMEAV
PEGDWFCTVCLAQQA
SSSGRHR
SVNKVTCLVCRKG
ANDEFLLLCDGCDR
GCHIYCHRPKMEAV
PEGDWFCTVCLAQQV

29
D1717A GCTGTCCCAGAAG
GAGCTTGGTTCTG
TACTGTC
N1675A AGATTGGAGGTTC
TGTCGCCAAAGTG
ACCTGCCTGGT

GACAGTACAGAA
CCAAGCTCCTTC
TGGGACAGC

SVNKVTCLVCRKG
DNDEFLLLCDGCDR
GCHIYCHRPKMEAV
PEGAWFCTVCLAQQV
ACCAGGCAGGTCA HREQIGGSVNKVTCLV
CTTTGGCGACAGAA CRKGDNDEFLLLCDGC
CCTCCAATCT
DRGCHIYCHRPKMEAV
PEGAWFCTVCLAQQV

After the mutagenesis reaction, Dpn I digestion was done at 37°C for 2hours to
destroy the template (hBAZ2A-PHD wild type DNA). Enzyme inactivation of the Dpn I
was done at 80°C for 20mins to inactivate the enzyme after digesting the parental
supercoil dsDNA. The mutants were transformed into XL 10-gold competent cells and
then incubated on a kanamycin agar plate at 37°C for 14hours. Colonies obtained on the
kanamycin agar plates were cultured and allowed to grow at 37°C for 18hours in a
kanamycin/LB media and then miniprep performed according to the QIAprep spin
miniprep kit protocol (QIAGEN). 1% DNA agarose gel was prepared in 1x TAE buffer;
pH 8.0 and the samples run to determine the presence of the mutants (Figure 2.8). The
samples were then packaged and sent for sequencing (Genscript) to determine the right
nucleotide sequence of each of the mutants.
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Figure 2.8. Agarose gel electrophoresis of hBAZ2A mutants before DNA samples were sent for
DNA sequencing. Lane 1 (hBAZ2A wild type) was run as marker to confirm the size and
behavior of the plasmid in the agarose gel.

Transformation, Expression and Purification of Mutants
After confirming the DNA sequences of all the mutants, they were transformed
into HI-Control® BL21 (DE3) SOLOs Chemically Competent cells (see transformation).
Solubility test and small-scale expression was done to select the best colonies for all the
mutants. 4-liter culture was prepared for each mutant and purified as described above for
the purification of the wild type.

Figure 2.9. SDS-PAGE gel showing the expression of some of the mutants of hBAZ2A-PHD: For each of
them, an induced and an uninduced sample was run to clearly show that proteins are being expressed. The
protein was run with a 12% SDS-PAGE gel in a 1x running buffer with a 120 voltage for 60 minutes.
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Figure 2.10 (A-D). Chromatograms showing the FPLC profile peaks of purified V1674A, D1688A,
E1689A and L1692A respectively. They were all run at 4°C in 25mM phosphate buffer (150mM NaCl salt,
pH of 7.6). The tubes corresponding to these peaks were concentrated using an ultra-filtration tube with a
10kDa molecular weight cut off.
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Figure 2.10 (E-H). Chromatograms showing the FPLC profile peaks of purified L1693A, D1695A,
D1698A and V1713A respectively.
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Figure 2.10 (I-K). Chromatograms showing the FPLC profile peaks of purified E1711A, E1715A, and
V1728A respectively. All the proteins were eluted with 100ml of 150mM imidazole in 1x phosphate buffer
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and concentrated to 4ml before loading into the AKTA prime FPLC at 4°C. The column used was the
HiLoad 26/600 superdex column. The tubes corresponding to the peaks were concentrated to 0.1mM for
the ITC measurement.

(L)
190.93

mAu

25.0

20.0

15.0

10.0

5.0

0.0
0

50

100

150

200

250

300

350

ml

(M)

191.94

mAu

25.0

20.0

15.0

10.0

5.0

0.0
0

50

100

150

200

250

300

350

ml

35
(N)

194.48

mAu
40.0

30.0

20.0

10.0

0.0
0

50

100

150

200

250

300

350

ml

Figure 2.10 (L-N). Chromatograms showing the FPLC profile peaks of purified D1686A, D1717A, and
N1675A respectively.

Synthetic Peptides
98% pure Histone H3 synthetic peptide with residues 1-11 (H3-1-11W) was
ordered from Genscript for the binding studies of the wild type and the mutants of
hBAZ2A-PHD proteins. The W in the synthetic peptide sequence represents C-terminal
Tryptophan residue. H3-1-11W. The C-terminal Tryptophan residue in the peptide was
used for estimating peptide concentrations by absorbance using the computed molar
extinction coefficient66, which is 5.5M-1cm-1. The purity of the Histone H3-1-11W
peptide was confirmed with mass-spectroscopy.
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Synthetic Peptide and Recombinant Protein Concentration Measurements
The wild type and mutant proteins of hBAZ2A-PHD from the FPLC HiLoad
26/600 superdex column were concentrated using the Amicon Ultra-15 Centrifugal Filter
Units (Millipore) with a 10kDa molecular weight filter since the size of the recombinant
proteins was 18.4kDa. The concentration was determined by using the UV-Vis Nanodrop
Spectrophotometer to measure the absorbance of the proteins at 280nm (which is the
absorption wavelength for tryptophan) and then the concentration calculated by using the
molar extinction coefficient obtained from ExPaSy ProtParam tool (a bioinformatics
software for computing the chemical and physical properties of proteins). The molar
extinction coefficients of the hBAZ2A-PHD proteins and Histone H3 1-11W peptide are
8.48 M-1cm-1 and 5.5 M-1cm-1 respectively.
The concentrations were confirmed by using the Bradford Protein Assay standard curve
(Figure 2.7) that was generated by the using Quick Start Bradford Protein Assay protocol.

Isothermal Titration Calorimetry (ITC)
The peptides and recombinant proteins (wild type hBAZ2A and mutants) for ITC
were both prepared in the same buffer (25 mM phosphate, 150 mM sodium chloride at
pH=7.6). The thermodynamics of binding between a protein and the synthetic peptides
were studied using MicroCal ITC200 (GE Healthcare) with protein (0.1-0.15 mM) and
peptide (10 fold higher) respectively loaded in the cell and syringe at 25°C. Twenty 2µlinjections with a 3-minute injection-interval, with a syringe stirring speed of 1000 rpm
were used for the titrations. DG° of peptide binding at 25°C was computed as –RTln (Ka)
where R, T and Ka are respectively the gas constant, temperature and association
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constant. DDG° for a residue’s energetic contribution is estimated as DDG° = DG°mutant DG°wildtype. All titrations were carried out in identical conditions of buffer and
temperature. In the case of many of the mutants, no binding was observed (i.e. negligible
amount of observed heats) and data fitting was unreliable to the observed enthalpy. In
such cases it was assumed that DDG° (>> 1.5 kcal.mol-1) was large. Tryptophan residue
of the PHD finger was used for estimating protein concentrations by absorbance using the
computed molar extinction coefficient66. Titrations were also performed at 250 mM
sodium chloride buffer (25 mM phosphate at pH=7.6) to check the influences of
electrostatics on the protein-peptide interactions. Binding measurements (titrations) for
each protein was run in triplicate to confirm the data.

RESULTS AND DISCUSSIONS
Contribution of electrostatics on peptide binding
Histone H3 peptide is positively charged, and there is a considerable distribution of
negatively charged residues around the binding surface of BAZ2A-PHD finger (Figure
2.11A). It is likely that electrostatics would influence peptide-binding interactions. For a
qualitative estimate of the influence of electrostatics, we carried out experiments at both
150mM NaCl salt and 250mM NaCl salt for the wild type protein. It was observed that,
by increasing the salt concentration by 100mM, the free energy (ΔG) of peptide binding
at 25°C becomes unfavorable by ~0.7kcal/mol (or 3.35 fold affinity drop) confirming the
role of electrostatics in the overall binding interactions (Figure 2.11A, 2.12). This
suggests that the binding is driven by electrostatics hence higher salt concentration
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shields the electrostatics. Thus, in selecting the control residues, among several other
possible residues, distal negatively charged residues (E1711 and E1715) were preferred.
The peptide in complex with BAZ2A-PHD possesses three positive charged centers,
which are normally involved in the electrostatic interaction. These centers are: (i) the Nterminal NH3+ -group, (ii) the CZ- atom of Arginine-2 and (iii) the NZ- atom of Lysine-4.

A

Histone H3-1-5 peptide
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control mut ation sites

Figure 2.11. (A) Electrostatic potential (isocontour value of ± 76.3 kT/e) surface representation of the
BAZ2A PHD bound to the H3-1-5 residue peptide (splitpea), (B) Side-chain atoms of BAZ2A-PHD
residues that are mutated to Alanine in this study are represented in sticks (light-pink). Positions of interest
are labeled as L1, L2, D1, and D2. (C) Side-chains of positions of control mutations are also represented in
sticks.
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Figure 2.12. ITC binding studies between histone H3 unmodified N-terminal peptide and wild type of
BAZ2A-PHD at (A) 150mM NaCl Salt and (B) 250mM NaCl salt. (C) Overlayed titration profiles of the
wild types at different salt concentrations. The Kd is reduced by 3.35 fold by changing the salt from
250mM to 150mM.

Dissecting the energetic contributions of BAZ2A-PHD residues
The recently reported 1.9-Å X-ray structure of BAZ2A-PHD47(pdb code 4q6f) in
complex with the unmodified histone H3 N-terminal peptide (Figure 2.11A) is used here
as the starting point for inferring the energetic contributions of BAZ2A-PHD residues
towards peptide binding. BAZ2A-PHD residues that undergo a change in the accessible
surface area, ∆ASA, ≥ 10Å2 of the side chain atoms are considered for probing the
energetic contributions (Figure 2.11B, see Methods) by mutagenesis. Seven BAZ2APHD residues lose ~15Å2 or more of their side-chain surface area upon complex
formation, and we consider these residues as the primary contacts for histone H3 peptide
(Figure 2.11B). However, D1698 (∆ASA = 0) is also included in the list of residues for
mutagenesis (Figure 2.11B). This is because, in an earlier study7, it had been noted that
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D1698 of BAZ2A is the second of the pair of Asp residues in the PHD treble-clef
knuckle xCDxCDx sequence pattern, a feature present in a distinct PHD subgroup that
includes the double PHD finger (DPF or also referred as the tandem-PHD-PHD) type of
modules (Figure 3.1). To probe the binding energetics by mutagenesis, we also included
three control residues (E1711, E1715 and V1728) that are either distal from the peptidebinding site (∆ASA @ 0) (Figure 2.11A, C). The selected eleven positions were
substituted to Alanine, and mutants were then purified for probing histone H3 peptide
binding energetics by isothermal titration calorimetry (ITC) (Figure 2.13-2.14 and Table
2.8). For comparison of the wild type protein’s peptide-binding behavior with that of the
rest of the mutants, ∆G and Kd at 25°C are summarized in table 2.8. We then probed the
eleven mutants to learn if factors in addition to electrostatics would contribute to the
overall binding energetics.
Mutations at three positions (L1692A, L1693A and D1695A) completely aborted
peptide binding, i.e. titrations with these mutants did not show any detectable enthalpy
change (Figure 2.13, 2.14(D-F) and Table 2.8). Based on the binding enthalpy, for the
rest of the mutants, we observed a range of binding behaviors (Figure 2.13-2.14, Table
2.8). However, none of them completely disrupted peptide binding. Thus, we anticipate
that L1692A, L1693A and D1695A make very large energetic contributions towards
peptide binding, and these residues likely dominate the peptide binding energetics. It is
interesting to note two nonpolar residues (L1692 and L1693) are among the residues
dominating the binding energetics between the two oppositely charged interacting
partners. We discuss the details of the binding energetic observations of BAZ2A-PHD
finger in the context of the PHD superfamily in the next chapter.
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Table 2.8. (A) A listing of the structural (DASA) and thermodynamic (Ka, Kd, DGo) properties of the
mutated BAZ2A-PHD positions listed in the study
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Table 2.8. (B) A listing of the structural (DASA) and thermodynamic (Ka, Kd, DGo) properties of the
mutated BAZ2A-PHD positions that are remote from the peptide binding site (distal site) but disrupts
peptide binding.

Mutant

ΔASASC (Å2)

Ka (M-1)

D1686A

0.00

X

X

X

D1717A

0.95

X

X

X

N1675A

20.23

X

X

X

Kd (µM)

ΔG°(Kcal/mol)

Figure 2.13 (A) ITC binding studies between histone H3 unmodified N-terminal peptide, and wild type,
mutants of BAZ2A-PHD. A representative isothermal calorimetric titration (top) of H3-1-9 peptide
(syringe) into protein (cell) is shown for the wild type protein while exothermic heats (bottom) exchanged
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per mol of injectant as a function of the molar ratio of peptide to protein is overlayed for all titrations for
convenience. (B) DGo of the forward binding reaction for the wild type and mutants are shown as bar. For
convenience -DGo is shown. Residues that contribute more than 1 kcal/mole of free energy are below the
black dotted line. Red bars for positions where binding was not detected in ITC experiments.
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G

H

∆
∆

∆
∆

Figure 2.14.(A-H) ITC binding studies between histone H3 unmodified N-terminal peptide and mutants of
BAZ2A-PHD. A representative isothermal calorimetric titration (top) of H3-1-9 peptide (syringe) into
protein (cell) is shown for the mutant proteins while exothermic heats (bottom) exchanged per mol of
injectant as a function of the molar ratio of peptide to mutant proteins. From A to H are V1674A, D1688A,
E1689A, L1692A, L1693A, D1695A, D1698A and V1713A respectively.

Contributions of negatively charged residues at BAZ2A interface
Since BAZ2A belongs to a subtype that is characterized by the presence of a pair
of negatively charged residues at the treble clef knuckle, we first wanted to understand
the contributions of the BAZ2A D1695 (D1 position) and D1698 (D2 position) residues
as a first step so we can better understand in the context of subtype structure in the next
chapter. The substitution of D1695 severely compromised binding. Side-chain
carboxylate at D1 is engaged in a salt bridge mediated interaction with the H3Arg2
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residue. The complete loss of binding upon D1695 substitution was expected due to the
loss of the electrostatic interaction between D1695 and H3Arg2, and thus D1695 has a
very large energetic contribution. DDG for BAZ2A D1698 (D2 position) was however,
0.67 kcal/mole (Figure 2.13, 2.14F-G and Table 2.8). The contribution of D1698 (D2
position, 0.67 kcal/mole) could be less than that of the D2 position of other members
because of a structural deviation of the treble clef xCDxCDx knuckle in BAZ2A PHD
noted in Figure 2.15. In comparison with what is typically observed in other PHD fingers,

FIGURE 5

the structural deviation of the knuckle places BAZ2A D1698 farther away from the
H3Arg2 residue. This structural deviation is also reflected in the loss of the surface area

A

upon complex formation.
H3

R2

BAZ2A
H3
RF1

UH
D1695

R2

H3

D1
RF1
UH
6A

KAT

R2
3
DPF D2
D1698

Treble clef knuckle
6A
KAT
Figure 2.15. BAZ2A-PHD treble clef knuckle Asp pair: Structural deviation and distances between
oppositely charged atoms among the PHD_nW_DD subtype structures anchoring histone H3-Arginine 2

C

residue.

PHD_nW

PHD_nW_DD
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BAZ2A D1698, with 0.0Å2 DASAsc, having a non-zero energetic contribution
towards peptide binding also suggested that other negatively charged residue control
mutations (Figure 2.11C) might have non-zero energetic contributions possibly through
long-range electrostatics. The DDG for BAZ2A E1711A and E1715A control mutations
are respectively 0.09 and 0.94 kcal/mol (Figure 2.17-2.18, Table 2.8). The peptide in
complex with BAZ2A-PHD possesses three positive charge centers: (i) the N–terminal
NH3+–group, (ii) the CZ–atom of Arg2 and (iii) the NZ–atom of Lys4. For the E1715
residue, closest of these three peptide positive charge centers is the N–terminal NH3+–
group at 6.4Å away (Figure 2.17A). For comparison, the closest positive charge center
for the D1 residue carboxylate oxygen atoms is the H3R2-CZ atom at 3.46 ± 0.04Å in
BAZ2A where we note large energetic contribution from the D1 position. Noting the
distances of these distal site positions (E1711 and E1715) in BAZ2A, it is unlikely that
the energetic contributions of these sites can be explained merely by electrostatics.
Recent reports on distal site perturbations modulating binding in small sized domains
suggest that67, 68, in addition to electrostatics, other structural effects such as the influence
on protein dynamics and/or change in the structure could be associated with contributions
of these distal sites. Influence of distal site perturbations on binding is not uncommon for
PHD fingers, e.g. binding of BCL9 peptide at a distal site on Pygo-PHD (Figure 2.17B)
enhances the PHD canonical site’s affinity for histone H3 by 2-3 fold69. Probing distal
site perturbations of mutations will however require further study. The next chapter will
try to determine if these positions show a subtype specific enrichment for the distal
negatively charged residue.
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Figure 2.16A. Negatively charged residue control mutants. ITC binding studies between histone H3
unmodified N-terminal peptide and mutants of BAZ2A-PHD. A representative isothermal calorimetric
titration (top) of H3-1-9 peptide (syringe) into protein (cell) is shown for the mutant proteins while
exothermic heats (bottom) exchanged per mol of injectant as a function of the molar ratio of peptide to
mutant proteins. (A) on left is E1711A, and (B) on right is E1715A, (C) below V1728A.

kcal mol-1 of injectant

0.0
-2.0
-4.0

E1715A

-6.0
-8.0

E1711A
V1728A

-10.0
-12.0
0.0

0.5

1.0

1.5

2.0

2.5

Figure 2.16B. Overlayed titration profiles of the control mutants: ITC binding studies between histone H3
unmodified N-terminal peptide and mutants of BAZ2A-PHD
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Figure 2.17A. Distances of positive charge centers from the site of mutation (left), and for comparison,
distances for D1 position (right).

B

Figure 2.17B. Structural example of the distal site perturbation of Pygo-PHD by BCL9 peptide.
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with the fitted enthalpy.

Distal Mutations that Disrupts Histone H3 Peptide binding
V1728

We looked at 3 other positions D1686, D1717 and N1675 (Figure 2.19) on the
control mutation sites

hBAZ2A-PHD surface, which were at a distal site from the histone H3 binding site. Our

!"!

observation from the energetics was however quite interesting. All these 3 positions had
significant contribution towards the protein-peptide complex formation since their
mutations caused the interaction to be aborted. It is however not clear whether the
influence is due to a long range electrostatic70, 71 hence a mutation leads to the significant
drop in the energetics. The observation could also be as a result of a dynamic motion of
these positions hence their mutations causes the interruption of their coupling effect on
the protein-peptide complex formation68, 72-79. All the possible scenarios could be
confirmed by doing a structural study analysis, which will be conducted as the next phase
of the work.
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Figure 2.19. Distal site residue mutants: ITC binding studies between histone H3 unmodified N-terminal
peptide and mutants of BAZ2A-PHD. A representative isothermal calorimetric titration (top) of H3-1-9
peptide (syringe) into protein (cell) is shown for the mutant proteins while exothermic heats (bottom)
exchanged per mol of injectant as a function of the molar ratio of peptide to mutant proteins. (A) D1686A
(B) D1717A (C) N1675A- The Stoichiometry (N) could not be fitted for this mutant hence the data fitting
is unreliable to the observed enthalpy. As a result, DDG° (>> 1.5 kcal.mol-1) is large or the observed
amount of heat is considered to be negligible.

55
CHAPTER III
BAZ2A AND PHD ZINC FINGER SUBTYPE
ABSTRACT
Although the plant homeodomain (PHD), a binuclear interleaved Zn-chelating
domain finger superfamily is well known for its site-specific readouts of histone tails,
mechanistic details of the readouts remain poorly understood. Starting with BAZ2APHD (one member of the PHD_nW_DD subtype), key histone peptide anchoring residue
positions were first identified by site-specific mutagenesis. Loss of interfacial packing,
due residue substitution, contributes to the observed binding energetics. The peptide
anchoring residue positions (ΔΔG≥ 1.0kcal/mol) of BAZ2A-PHD, interestingly, are
enriched in specific type of residues in a subtype specific manner. The energetic
contribution of the identified positions were further confirmed by mutagenesis in other
three members of the subtype (UHRF1-PHD, KDM5B-PHD, KAT6A-PHD) that
included pairs sharing even less than 40% sequence identity with each other. Despite low
sequence similarity, mutations cause similar consequences in histone H3 binding
suggesting a strong similarity in the binding mechanism.
The experimental data suggests that the binding mechanism of the PHD_nW_DD
likely originated early to anchor residue 1-3 of histone H3, featuring a characteristic
treble clef knuckle Aspartate residues for anchoring the peptide Arginine hotspot while
the acidic patch residues contribute to the helical conformation of N-terminal histone H3.
A set of non-polar amino acids is among the residues enriched in the PHD_nW_DD
subtype, and these non-polar amino acids tightly pack against the peptide residues with
small side-chains, present on either side of the peptide hotspot Arginine residue.
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INTRODUCTION
From chapter two, we experimentally discovered two categories of mutations that
disrupt peptide binding: (1) Type-A: positions that are in contact with the peptide and (2)
Type-B: positions that are remote from the peptide-binding site (distal site). For this
chapter of the dissertation, we focused on understanding the biochemical basis of the
effects of Type-A mutations using recombinant protein chemistry and biophysical
chemistry. Moreover, having observed the energetics of the histone binding mechanism
of histone H3 peptide and human BAZ2A-PHD, we wanted to ascertain if the features we
observed were features that could be said to be true of the PHD_nW_DD subtype or they
were features that were unique to BAZ2A-PHD.
To confirm this, three members of the PHD_nW_DD subtype were selected. One
member, KDM5B-PHD7, 18, 80 had sequence identity of 60% but the other two, UHRF1PHD19 and KAT6A-PHD81 had sequence identity of less than 40% (Figure 3.1B and 3.2).
Wild types of these proteins were cloned and purified for the biophysical measurements
using ITC. Site-specific mutations were also performed on these selected members
(Type-A mutations). For simplicity, the D1695, D1698, L1692, and L1693 positions in
BAZ2A-PHD will be referred to as D1, D2, L1, and L2 respectively in corresponding
positions in selected members of the subtype.

57

Figure 3.1. The chosen PHD fingers: (A) Cartoon representation of the domain organization of proteins
bearing the distinct subfamily of PHD (blue). This PHD subtype occurs in combination with variety of
other domains. (B) Double PHD Finger (DPF) are aligned with single PHD finger sequences to highlight
the common feature of treble clef Aspartate residues. UniProt accession ids and residue boundaries are
indicated left of the alignment. Non-redundant sequences (85% sequence identity) are used to generate the
alignment using muscle. PHD1 and PHD2 of DPFs respectively are in gray and black, with KAT6A DPF
(bottom, right) highlighting the location of treble clef Asp residues in DPF-PHD2. Among subtype, 10%
are DPFs and 90% are isolated PHD.
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Figure 3.2. PHD, zf-CW and the L1 position: (A) MUSTANG structural alignment of PHD finger. The
protein names are on the left of the alignment, and pdb ids, residue boundary and resolution are on the right
of the alignment. PHD fingers with < 40% sequence identity are chosen, and the ‘]’ symbol to the right of
the alignment indicates some pairs with sequence slightly above 40% sequence identity. (B) MUSTANG
structural alignment of zf-CW domains that have < 40% sequence identity with one another. The dotted
lines between the zf-CW and PHD structural alignments indicate the segment containing the strandknuckle-strand. L1 and L2 positions in the alignment are respectively in green and red color. (C) The
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structure of MORC3 zf-CW domain in complex with histone H3K4me3 peptide (left). The surface mesh
represents contact between H3A1-CH3 and L1. The structure BPTF PHD finger (right) with a similar
pattern of aromatic cage residues as that of zf-CW. (D) Similarity in the sequence logo between zf-CW and
PHD_W subtype for the pair of strands that augments the peptide.

MATERIALS AND METHODS
DNA constructs and Mutagenesis of Subtype proteins
The wild type proteins selected for this section of the work had already being
cloned and sequences verified from GenScript by Dr. Chakravarty’s lab7. Briefly,
recombinant His-tag fusion of hUHRF1 PHD (residues 299-367 UniProt ID
Q96T88/UHRF1_HUMAN) and hKAT6A DPF (residues 196-319 UniProt ID
Q92794/KAT6A_HUMAN) were cloned into a modified pET28A vector using BamHI
and XhoI restriction sites. The pET28A modification is that the Thrombin protease
cleavage site DNA sequence was modified to incorporate BamHI restriction site without
altering the protein sequence. PCR (polymerase chain reaction) amplification of synthetic
DNA representing the sequences of hUHRF1 PHD and hKAT6A DPF were first carried
out for creating the desired constructs. Synthetic DNA molecules were obtained from
GeneScript. Mutants of hUHRF1 PHD (L344A, M345A, and D350A) and hKAT6A DPF
(L279A, F280A, and D285A) were created by site directed mutagenesis (refer to chapter
2 for procedure and conditions). The recombinant GST fusion hKDM5B PHD (residues
305-366 of UniProt ID Q9UGL1/KDM5B_Human) and hAIRE PHD (residues of 294343 UniProt ID O43918/AIRE_HUMAN) used here was taken from an earlier study done
by the lab7. hKDM5B PHD and hAIRE PHD were originally cloned into pGEX-4T3
vector. hKDM5B PHD mutants (D331A, L325A, L326A) and hAIRE PHD mutant
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(C310L) were created using site directed mutagenesis (refer to chapter 2). In total, 14
proteins (4 wild types and 10 mutants) created in this section of the study are used to
probe the peptide binding mechanisms of PHD finger subtypes.

Table 3.1. Primers used for the Site Directed Mutagenesis of the subtype Proteins. The letter colored red is
the site of mutation. Primers were purchased from Integrated DNA Technologies (IDT).

Protein

Forward Primer

Reverse Primer

Protein sequence

UHRF1_Wildtype

CGCGGATCCG
GTCCGAGCTG
CAAGCACTG

CCGCTCGAGTT
ACGCGTCGTTA
CGGCATTCCG

UHRF1_D350A

ATGTGCGACG
AGTGCGCTAT
GGCGTTCCAC
ATC

GATGTGGAAC
GCCATAGCGC
ACTCGTCGCAC
AT

UHRF1_L344A

CAGGACCCGG
ATAAGCAAGC
GATGTGCGAC
GAGTGCGAT

ATCGCACTCG
TCGCACATCG
CTTGCTTATC
CGGGTCCTG

UHRF1_M345A

GACCCGGATA
AGCAACTGGC
GTGCGACGAG
TGCGATATG

CATATCGCAC
TCGTCGCACG
CCAGTTGCTT
ATCCGGGTC

KAT6A_Wildtype

CGCGGATCCC
ACATGCTGGA
GCTGCCGCAC

CCGCTCGAGT
TACGGACGGC
AAATTTGGCA
GATC

KAT6A_D285A

TTCTGCGAC
AGCTGCGCT
CGTGGCTTT
CACATG

CATGTGAAAG
CCACGAGCGC
AGCTGTCGCA
GAA

GPSCKHCKDDVNRLCR
VCACHLCGGRQDPDK
QLMCDECDMAFHIYC
LDPPLSSVPSEDEWYCP
ECRNDA
GPSCKHCKDDVNRLCR
VCACHLCGGRQDPDK
QLMCDECAMAFHIYC
LDPPLSSVPSEDEWYC
PECRNDA
GPSCKHCKDDVNRLCR
VCACHLCGGRQDPDK
QAMCDECDMAFHIYC
LDPPLSSVPSEDEWYCP
ECRNDA
GPSCKHCKDDVNRLCR
VCACHLCGGRQDPDK
QLACDECDMAFHIYC
LDPPLSSVPSEDEWYC
PECRNDA
HMLELPHEKDKPVA
EPIPICSFCLGTKEQN
REKKPEELISCADCG
NSGHPSCLKFSPELT
VRVKALRWQCIECK
TCSSCRDQGKNADN
MLFCDSCDRGFHME
CCDPPLTRMPKGMW
ICQICRP
HMLELPHEKDKPVA
EPIPICSFCLGTKEQN
REKKPEELISCADCG
NSGHPSCLKFSPELT
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VRVKALRWQCIECK
TCSSCRDQGKNADN
MLFCDSCARGFHME
CCDPPLTRMPKGMW
ICQICRP
KAT6A_L279A
GGTAAAAACG GCAGCTGTCG
HMLELPHEKDKPVA
CGGATAACAT CAGAACGCCA EPIPICSFCLGTKEQN
GGCGTTCTGC TGTTATCCGCG REKKPEELISCADCG
GACAGCTGC
TTTTTACC
NSGHPSCLKFSPELT
VRVKALRWQCIECK
TCSSCRDQGKNADN
MAFCDSCDRGFHME
CCDPPLTRMPKGMW
ICQICRP
KAT6A_F280A
AACGCGGATA ACGATCGCAG
HMLELPHEKDKPVA
ACATGCTGGC CTGTCGCAGG
EPIPICSFCLGTKEQN
CTGCGACAGC CCAGCATGTT
REKKPEELISCADCG
TGCGATCGT
ATCCGCGTT
NSGHPSCLKFSPELT
VRVKALRWQCIECK
TCSSCRDQGKNADN
MLACDSCDRGFHME
CCDPPLTRMPKGMW
ICQICRP
KDM5B_Wildtype CGCGGATCC
GAATGTAGT
NAVDLYVCLLCGS
AATGCTGTG
AAGCCACAA
GNDEDRLLLCDGC
GACCTGTATG GAATAA
DDSYHTFCLIPPLH
CTCGAGCGG
DVPKGDWRCPKCL
AQECSKPQE
KDM5B_D331A
TGTGATGGCT ATGGTAACT
NAVDLYVCLLCGS
GTGCGGACAG GTCCGCACA
GNDEDRLLLCDGC
TTACCAT
GCCATCACA
ADSYHTFCLIPPLH
DVPKGDWRCPKCL
AQECSKPQE
KDM5B_L325A
AATGATGAAG ATCACAGCCA
NAVDLYVCLLCGS
ACCGGCTAGC TCACACAACG
GNDEDRLALCDGC
GTTGTGTGAT CTAGCCGGTC
DDSYHTFCLIPPLH
GGCTGTGAT
TTCATCATT
DVPKGDWRCPKCL
AQECSKPQE
KDM5B_L326A
GATGAAGACC GTCATCACAGC NAVDLYVCLLCGS
GGCTACTGGC CATCACACGCC GNDEDRLLACDGC
GTGTGATGGC AGTAGCCGGTC DDSYHTFCLIPPLH
TGTGATGAC
TTCATC
DVPKGDWRCPKCL
AQECSKPQE
AIRECGCGGATCC
CCGCTCGA
KNEDECAVCRDG
AAGAATGAG
GTTACTCC
GELICCDGCPRAF
GACGAGTGTG TGGACTGT
HLACLSPPLREIPS
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PHD1_Wildtype
AIREPHD1_C310L

GACGGCGGGG
AGCTCATCCT
CTGTGACGGC
TGCCCTCGG

TGCCTG

GTWRCSSCLQATVQE

CCGAGGGCAG
CCGTCACAGA
GGATGAGC
TCCCCGCCGTC

KNEDECAVCRDG
GELILCDGCPRAF
HLACLSPPLREIPS
GTWRCSSCLQATVQE

Table 3.2. The cDNA UniProt ID and nucleotide sequence of the PHD finger subtype proteins

cDNA UniProt ID

Nucleotide Sequence

hUHRF1 PHD (residues 299-367
UniProt ID
Q96T88/UHRF1_HUMAN)

GGTCCGAGCTGCAAGCACTGCAA
AGACGATGTGAACCGTCTGTGCC
GTGTTTGCGCGTGCCACCTGTGC
GGTGGCCGTCAGGACCCGGATAA
GCAACTGATGTGCGACGAGTGCG
ATATGGCGTTCCACATCTATTGCC
TGGACCCGCCGCTGAGCAGCGTG
CCGAGCGAGGATGAATGGTATTG
CCCGGAATGCCGTAACGACGCG
CACATGCTGGAGCTGCCGCACGAA
AAGGACAAACCGGTGGCGGAGCCG
ATCCCGATTTGCAGCTTCTGCCTGG
GTACCAAGGAGCAGAACCGTGAAA
AGAAACCGGAGGAACTGATCAGCTG
CGCGGATTGCGGTAACAGCGGCCAC
CCGAGCTGCCTGAAGTTTAGCCCGG
AGCTGACCGTGCGTGTTAAAGCGCT
GCGTTGGCAGTGCATTGAATGCAAG
ACCTGCAGCAGCTGCCGTGACCAAG
GTAAAAACGCGGATAACATGCTGTT
CTGCGACAGCTGCGATCGTGGCTTTC
ACATGGAATGCTGCGACCCGCCGCTG
ACCCGTATGCCGAAAGGCATGTGGAT
CTGCCAAATTTGCCGTCCG
AATGCTGTGGACCTGTATGTCTGTCTTT
TATGTGGCAGTGGCAATGATGAAGACC
GGCTACTGTTGTGTGATGGCTGTGATGA
CAGTTACCATACCTTTTGCTTGATCCCAC
CTCTCCATGATGTTCCCAAGGGAGACTGG
AGGTGTCCTAAGTGTTTGGCTCAGGAATG
TAGTAAGCCACAAGAA
AAGAATGAGGACGAGTGTGCCGTGT
GTCGGGACGGCGGGGAGCTCATCTG

hKAT6A DPF (residues 196-319
UniProt ID
Q92794/KAT6A_HUMAN)

hKDM5B PHD (residues 305-366 of
UniProt ID
Q9UGL1/KDM5B_Human)

hAIRE PHD (residues of 294-343
UniProt ID O43918/AIRE_HUMAN)
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CTGTGACGGCTGCCCTCGGGCCTTCC
ACCTGGCCTGCCTGTCCCCTCCGCTC
CGGGAGATCCCCAGTGGGACCTGGAG
GTGCTCCAGCTGCCTGCAGGCAACAG
TCCAGGAG

Expression and purification of proteins and their Mutants
The recombinant subtype PHD finger proteins and their mutants were purified as
described in chapter 2. Briefly, E. coli BL21 (DE3) cells expressing the protein from
pET28a vector were induced at OD600 = 0.6-1.0 with 1 mM IPTG grown overnight at
16°C. The fusion proteins were isolated using His-tag affinity chromatography. The
proteins were then purified to homogeneity by gel filtration using HiLoad 26/600
superdex column using FPLC. Protein purity was confirmed by SDS-PAGE.
Recombinant hUHRF1 PHD and its mutants (L344A, M345A, and D350A), hKAT6A
DPF and its mutants (L279A, F280A, and D285A) were all purified similarly as
described for hBAZ2A PHD following the His-tag affinity chromatography step.
Recombinant hKDM5B PHD and its mutants (D331A, L325A and L326A) were purified
as described in Chakravarty et al. 7 using the pGEX-4T3 vector constructs. Similarly,
recombinant hAIRE PHD and its mutant (C310L) were purified using the pGEX-4T3
vector constructs. Briefly, the fusion proteins were isolated using GST affinity
chromatography (Pierce glutathione agarose, Thermo scientific). GST tag was eliminated
by overnight human alpha thrombin (Haematologic Technologies) digestion at 4°C prior
to FPLC. Remaining purification steps were same as that of the hBAZ PHD in chapter 2.
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Figure 3.3. (A-D) Chromatograms showing the FPLC profile peaks of purified hUHRF1-PHD, (A)
Wildtype, (B) D350A, (C) L344A, and (C) M345A respectively. All the proteins were eluted with 100ml
150mM imidazole in 1x phosphate buffer and concentrated to 4ml before loading into the AKTA prime
FPLC at 4°C. The tubes corresponding to the peaks were concentrated to 0.1mM for the ITC measurement.
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Figure 3.4. (A-D) Chromatograms showing the FPLC profile peaks of purified hKAT6A-PHD, (A)
Wildtype, (B) D285A, (C) L279A, and (D) F80A respectively. All the proteins were eluted with 100ml
150mM imidazole in 1x phosphate buffer and concentrated to 4ml before loading into the AKTA prime
FPLC at 4°C. The tubes corresponding to the peaks were concentrated to 0.1mM for the ITC measurement.
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Figure 3.5A. (A-D). Chromatograms showing the FPLC profile peaks of purified hKDM5B-PHD, (A)
Wildtype before GST cleavage, (B) Wildtype after GST cleavage, (C) D331A mutant before GST cleavage
and (D) D331A mutant after GST cleavage.
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Figure 3.5B. (E-F). Chromatograms showing the FPLC profile peaks of purified hKDM5B-PHD mutants,
(A) L325A mutant before GST cleavage, (B) L325A mutant after GST cleavage, (C) L326A mutant before
GST cleavage and (D) L326A mutant after GST cleavage.
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Figure 3.6B. Chromatograms showing the FPLC profile peaks of purified hAIRE-PHD1 C310L Mutant.
(Top) Before GST cleavage (Bottom) After GST cleavage

Synthetic Peptides
We used two synthetic peptides for this section of the study. They are: (i) Histone
H3 residues 1-11 (H3-1-11W), and (ii) Histone H3 residue 1-16 with acetylation at K14
(H3K14ac-1-16W). The W in the synthetic peptide sequence represents C-terminal
Tryptophan residue. H3-1-11W was used for the binding studies of the wild type and the
mutants of hUHRF1 PHD and hKDM5B PHD proteins. H3K14ac-1-16W peptide was
used for the binding studies of the wild type and the mutants of hKAT6A DPF. 98% pure
(confirmed with mass-spec) synthetic peptides were obtained from GeneScript. The Cterminal Tryptophan residue in the peptide was used for estimating peptide
concentrations by absorbance using the computed molar extinction coefficient66. These
peptides were used for ITC (Isothermal Titration Calorimetry) experiments. While this
work was in progress we had learned that hKAT6A DPF binds crotonylated H3K14cr-125 peptide with the highest affinity (Kd = 5.8µM)24 that is ~4.0 fold higher than that for
the H3K14ac peptide. Though we realize that it would have been ideal to have the
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peptide mutational analysis for hKAT6A DPF in the crotonylated H3K14cr-1-25 peptide
background, we carried out our experiments based on the earlier structural report of
hKAT6A DPF in complex with H3K14ac-1-1681. The ITC experiments, reported in the
earlier study of the interaction of hKAT6A DPF with H3K14ac-1-1681, were carried out
in 50 mM NaCl, while our ITC experiments were all performed at 150 mM NaCl. Under
these conditions, we do not observe the difference in the binding enthalpy between H3-116 and H3K14ac-1-16 peptides reported earlier81.

Alignments, PHD subtypes and Occurrence Frequency
10,858 PFAM-aligned sequences of PHD finger superfamily (PFAM82 accession
number PF00628.26) in STOCKHOLM 1.0 format were manually downloaded from the
PFAM ftp server. This alignment was first condensed by eliminating the alignment
positions having the symbol “.” in the original PFAM-alignment. The eliminated
positions in this step have the symbol “.” greater than 85% of times in the alignment
column. Sequences are extracted from the condensed alignment for creating a nonredundant set. Using CD-Hit83, redundant sequences at 85% sequence identity were
eliminated. The final non-redundant set contained 3,469 sequences. A part of the
condensed master PFAM-alignment of these 3,469 sequences is shown in Figure 3.7. In
this master alignment, the correspondence between residues in the original PFAM
alignment is not altered even though redundant sequences were eliminated. Without
altering the master alignment, PHD sequences are further segregated into subtypes
(Figure 3.7). A breakdown of these 3,469 sequences into subtypes: (i) PHD_W subtype
(1,425 sequences), and (ii) PHD_nW subtype (2,044 sequences). The PHD_nW subtype
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sequences were further segregated into: (a) PHD_nW_DD (692 sequences), (b) the
remaining 1362 PHD_nW sequences. PHD_nW_DD subtype refers to PHD_nW
sequences having a pair of Asp residues in the treble-clef knuckle of the PHD scaffold.
As described in Chakravarty et al.7, double PHD finger (DPF) scaffolds belong to this
subtype, and therefore, are categorized as a distinct subtype. As a control for the
PHD_nW_DD subtype, PHD_W subtype sequences were also segregated into: (a)
PHD_W_DD (234 sequences) and (b) the remaining 1191 PHD_W sequences.
PHD_W_DD subtype refers to PHD_W sequences having a pair of Asp residues in the
treble-clef knuckle of the PHD scaffold. As all of these groups are extracted from the
same condensed master PFAM-alignment, the alignment positions in each subtype
remain the same (Figure 3.7), and therefore, enable comparison of position specific
statistics among the subtypes. For example, Occurrence frequencies of residues at L1 and
L2 positions are calculated based on the 85% non-redundant master PFAM alignment and
the same alignment when partitioned into subtypes (Figure 3.7). Segregating the
sequences into subtypes was carried out by simply extracting sequences that met the
residue-type selection criterion for an alignment position, e.g. selecting sequences with
residue W/Y/F for the 26th position in the PFAM alignment (Figure 3.1) resulted in
PHD_W subtype and the remaining sequences are considered PHD_nW. Similarly,
selecting PHD_nW sequences with residue D at the 24th position in the PFAM alignment
(Figure 3.1) resulted in PHD_nW_DD subtype. The frequency of occurrence (pji) of the
jth amino acid (or residue type) in the ith alignment position (column) is the ratio
between the number of times the jth residue type appears in the ith alignment position
and the total number of sequences in the alignment (e.g. subtype alignment). Entropy for
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the ith position in this alignment was computed as, Entropy i = 4.39 - Σ (pji)×(log2 (pji)),
where pji is the probability of the jth amino acid at the ith alignment position (column)
and 4.39 is the value of maximum entropy. Entropy and pji for each PHD-subtype and
the PHD superfamily are calculated separately using the subtype specific alignments
shown in Figure 3.7.
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Figure 3.7. Master pfam alignment of PHD subtypes: (A) PFAM alignments of non-redundant (85%
sequence identity) PHD finger sequences (top) are further segregated into subtype specific sequences
(middle row and bottom). Sequences in the middle row subtypes are grouped based on the position number
‘26’ as having W/aromatic-residue (left, PHD_W subtype) and not having W/aromatic-residue (right,
PHD_nW). The bottom row sequences (PHD_nW_DD subtype) are extracted from PHD_nW with the
position number ‘24’ as having D. (B) The distributions of sequence identity in each subtype with the
dashed lines representing the median of sequence identity for each subtype.

The sequence logo (e.g., Figure 3.2, 3.15 and 3.17) was created using the online
version of the Skylign program84 by uploading PHD subtype specific alignments. For
sequence identity distribution (Figure 3.7B), sequence identity between sequences, i and
j, was calculated by comparing residue identity between the aligned positions of master
alignment. The observed median of the sequence identity distributions (Figure 3.7B,
dashed line) of a subtype (e.g. PHD_nW_DD) was used to set the sequence identity
cutoff (≤ 40%) for structural analysis.
All structural alignments and structural superposition operations (e.g., Figure 3.2,
3.8, 3.21), discussed here, were generated using MUSTANG85. MUSCLE86 sequence
alignment was also used for aligning: (a) double PHD finger (DPF) sequences (Figure
3.1A) with the remaining PHD_nW_DD sequences, and (b) sequences of a PFAM
domain with the GREMLIN87, 88 consensus sequence of the PFAM domain (see below,
Figure 3.8C). The sequences of the DPFs were first compiled as described earlier7 and the
sequences with 85% identical residues were eliminated after MUSCLE alignment.
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Mutual Information and PFAM domains
The mutual information (MI) of a residue pair of PFAM domain alignments was
calculated using the MISTIC89 web server by manually uploading the master PFAM
MSA (see above) in fasta format. The server calculates MI between pairs of columns in
the MSA. The calculation of frequency for each amino acid pair uses sequence weighting
and low count corrections in addition to comparing the computed frequency to the
expected pair-frequency with the assumption that the amino acids are non-correlated90.
The MI is represented as a weighted sum of the log-ratios between the observed and
expected amino acids pair frequencies90.
The server returns an MI value for each pair of residue positions in an MSA89. The
server also returns a cumulative mutual information score (CMI) for each MSA position
as the sum of MI values above a certain threshold (measured in terms of the MI Zscore91) for every amino acid pair where the particular residue appears. The CMI value
represents the degree of participation of a given MSA position in the mutual information
network91. The scores returned by the server correspond to positions of the first sequence
in the alignment. For convenience, in all our alignments for MI calculations by the
MISTIC server, the first sequence was reserved for the protein of interest having a known
structure, e.g. BAZ2A PHD in the PHD alignments. For the PDZ domain (PFAM
accession number PF00595.71), Drosophila inactivation-no-after-potential (InaD) protein
(INAD_DROME, pdbid: 1ihj) was used as the first sequence for MI analysis. An earlier
large-scale mutational analysis of PDZ peptide binding site had noted that 16-18
positions around the binding site confer binding specificity40. The binding site in that
study was defined by PDZ pdbids (1ihj, 1n7t, 2h2b, 1i92, etc.), and therefore, we used
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1ihj (INAD_DROME) as reference sequence as its structure is in complex with the
peptide. We used these 16-18 residue positions of INAD_DROME around its binding site
as a representative of the PDZ binding site (Figure 3.22A). To avoid confusion, the
residue numbering is that of INAD_DROME (Figure 3.22A, B, C), and for convenience,
their correspondence to PDZ family alignment is indicated in Figure 3.22B. The MI score
text file was reformatted as a matrix for creating MI density plot (e.g., Figure 3.21B,
3.22A) using the Matrix2png92 program. For display of the CMI scores mapped onto the
structure, the CMI score of a residue replaced the b-factor column of the corresponding
residue in the coordinate file. The 85% non-redundant alignments of PHD, PDZ and
Bromodomains (PFAM accession number PF00439.22) respectively had 3469, 4950 and
3477 sequences. For MI calculation of artificial sequences (see below), a set of 1000
sequences was used, and for PHD, BAZ2A sequence was once again placed at the first
sequence among the set of 1000 artificial sequences.

GREMLIN restraint score analysis
The pre-computed GREMLIN results (residue pair covariance and the consensus
sequence) of each PFAM domain were manually downloaded from the GREMLIN87, 88
webserver. The GREMLIN result text file, consisting residue pair covariance
information, contains three scores: (i) raw score (r_sco), (ii) scaled score (s_sco), and (iii)
probability score (prob). The scaled score (s_sco) represents covariance normalized
among the residue pair scores of a PFAM domain family87, 88. These paired scores
correspond to residues of GREMLIN consensus sequence. We use MUSCLE alignment
(see above) to get the correspondence between residues of the GREMLIN consensus
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sequence and the sequence of protein of interest (Figure 3.8C). GREMLIN also imposes
a sequence separation cutoff of 3 residues for a pair of residues to have covariance score.
Therefore, we do not have s_sco score for the D2−W pair, as the sequence separation is 2
in the PHD alignment (Figure 3.21B). A residue can have more than one s_sco score as it
can be in contact with several residues, and the highest s_sco score of a residue was
mapped on to the structure by manipulating the b-factor column of the coordinate file
(Figure 3.8A). The root mean squared deviation (RMSD) of Cα-atoms between the
corresponding positions in MUSTANG structural alignment is mapped to the structure by
replacing the b-factor column with the RMSD. PFAM domain structures with resolution
better than 2.2Å and having a sequence identity ≤ 40% with each other were considered
for the GREMLIN−RMSD analysis (Figure 3.8B). Even though there are several new
structures available for the PFAM domains analyzed here, for the GREMLIN−RMSD
analysis, pdbids listed as “DR PDB” record within the header of pfam alignment file in
STOCKHOLM 1.0 format were used for the convenience of running automated scripts,
and the PFAM alignment files were downloaded in 2015 November.
GREMLIN restraints for other PFAM peptide-binding domains (e.g., the PDZ
domain and bromodomain) were also examined for a comparative study. Here we utilized
the normalized GREMLIN restraint score (s_sco, see above) to map on to the structure to
visually infer the relative contributions of residues to folding (Figure 3.23A). Compared
with other PHD positions, the s_sco scores of the binding-site positions (including W, L2,
and D2) rank high (Figure 3.23A). In comparison, the s_sco scores of regions remote
from the binding site in the PDZ domain and bromodomain (Figure 3.23A) are higher
than that of the respective binding sites. This could also be attributed to the larger size of
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the PDZ domain (~80 residues), the bromodomain (~85 residues). Compared with the
~50-residue PHD scaffold, PDZ and bromodomain have many more inter-residue
contacts, which are necessary to fold the scaffold. The PHD peptide-binding site is also
positioned between two Zn-chelation centers, the key folding nucleus of the scaffold. The
higher s_sco score for binding-site residues of the PHD scaffold is therefore likely
justified. Consistent with the GREMLIN score, a comparison of the RMSD of crystal
structures of PFAM domain members sharing less than 40% sequence identity shows that
the structural deviation of the PHD peptide-binding site is smaller (Figure 3.23B).

Context Dependent Conformations of H3

H3-1-15

H3-1-8

H3-3-10

SFG29 (3met)

SAWADEE (4iur)

OG1

N-cap

T3

RBB4 (2yba)

H3-1-9

H3-1-10

ATRX (3qla)

H3-1-25

UHRF1 (3ask)

KAT6A (5b75)

Figure 3.8. Context dependent conformations of the H3 peptide: Structural representations of the
conformations of histone H3 involving regular (mediated by backbone hydrogen bonds) as well as nonregular secondary structures. This structural malleability of the disordered histone H3 segment thus likely
contributes to the one-to-many interactions93 of chromatin network hubs. Protein names and pdb ids are
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indicated. The role of H3T3 OG1 atom as N-cap is also observed in other H3 complexes. Additional factors
(other than those listed in Figure 3.18D bottom) might play important role in the context dependent
conformations of the H3 peptide. For example, with UHRF1, only the first helical turn of H3 is observed
where the tandem tudor domain (TTD) anchors the H3K9me3 residue, while 3 helical turns are observed
with DPFs where PHD1 of DPFs anchor the alkylated H3K14 residue.

Perturbed and Artificial Sequences
The multiple sequence alignment (MSA) of a PFAM domain consisting of 85%
non-redundant sequences is considered as the master MSA of the family. We consider a
position/column of a multiple sequence alignment (MSA) to be perturbed when we
permit only a specific type of residues to appear in that column. For example, W position
of PFAM PHD alignments (Figure 3.7, left) is perturbed when we permit only W, Y and
F to appear at the W position. The set of sequences that meets the condition is considered
here to be perturbed. Thus, PHD_W is considered to consist of perturbed sequences.
Mentioned above, the perturbed sequences retain the same alignment as that of the master
MSA. The occurrence frequency of amino acids in a column of the master alignment is
referred to as probability while that of a perturbed alignment as conditional probability,
i.e. a condition is imposed on the observed probability. The conditional probability of an
amino acid in a column is compared with its probability in the corresponding column as,
p = (conditional probability)

(probability) (see Figure 3.9A). For

value is considered as positive enrichment (
negative enrichment (

p, a positive

) and a negative value is considered as

) (Figure 3.9A, 3.7C). For convenience,

p is calculated for the

most frequent amino acid in a column. The probability of the most frequent residue at
each master PHD alignment position is shown in Figure 3.10A (right, top) and the
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corresponding conditional probability when perturbed by the D2 position in Figure 3.10A
(right, middle) as an example. We note negative enrichment for the W position when
perturbed by positions characteristic of the PHD_nW_DD subtype (Figure 3.9A, 3.10A
bottom). To avoid confusion, W and G positions refer to the same position, and a positive
enrichment of W is always associated with negative enrichment of G or the vice versa. As
PHD_nW_DD do not have W in the W-position, but a G, we use both symbols in the
discussion. We were cautious in interpreting enrichment for regions with a poor quality
of alignment. For example, the quality of alignment in the region housing BAZ2A
V1713, particularly, in the PHD_W group is less reliable (Figure 3.19B, 3.19D). This is
due to the insertions and deletion, as can be noted with PHD_W structures having helices
of varying lengths in this region (Figure 3.17D). Therefore, the estimate of occurrence
frequency of specific nonpolar residue (p = 0.23) for this region in the PHD_W subtype is
less reliable (Figure 3.19B).
We generated artificial sequences in the following manner. Amino acids, in the row
positions of each column of the master alignment, are assigned randomly such that the
probability of occurrence of an amino acid in that column remained the same as that of
the master alignment. In one iteration, 1,000 artificial sequences were generated, and 100
iterations were carried out. The following two conditions were checked: (i) E-value of an
artificial sequence was lower than a preset value (Figure 3.11A), and (ii) ΔEntropy (the
numerical difference between the entropy of the corresponding columns in the alignments
of artificial and natural sequences) was lower than a preset value (Figure 3.10C, right).
The E-value of sequences was calculated by hmm2search of HMMER294 package using
PFAM PHD hmm. The set of 1,000 artificial sequences were perturbed similarly, and the
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probability and conditional probability of the most frequent amino acids in the
corresponding columns of artificial and perturbed artificial sequences calculated (Figure
3.10B, C). In Figure 3.10B (right), the vertical arrow represents the conditional
probability of the indicated position when perturbed by the D2 position while the
horizontal arrows indicate the direction of the deviation of the conditional probability
obtained from artificial sequences from that obtained from real sequences. The direction
of the horizontal arrow also indicates, positive enrichment (right-hand direction) and
negative enrichment (left-hand direction).

Figure 3.9. Reciprocal enrichment and mutual information (MI) of PHD: (A) The occurrence frequency
(black bar) at an indicated position is altered (gray bar) as a result of perturbation. The gray bars represent
change in frequency (Dp) with respect to the horizontal line (black bar height). The perturbed positions are
indicated with encircled smaller fonts while encircled larger fonts represent positions undergoing frequency
change. For convenience, the most frequent amino acid at each position in the 85% non-redundant PFAM
and corresponding BAZ2A PHD sequences are at the top. (B) The mutual information (MI) between
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positions in the PHD finger family. The CMI score for each position is at the top and the matrix represents
the MI scores between positions. The distribution of the MI values (left) and the GREMLIN s_sco values
(right) between positions are at the bottom.
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Figure 3.10. Characteristics of PHD Natural and artificial sequences: (A) The characteristics of each
position of the aligned PHD natural sequences are categorized by entropy (left panel) and occurrence
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frequency of the most frequent residue (right panel). The top and the middle panels respectively are for
natural and perturbed natural sequences. As an example, the D2 position (red bar) is perturbed here and the
perturbation is achieved by retaining only Asp at the D2 position. The bottom panel is respectively for
changes in entropy (∆Entropy, left) and frequency (∆p, right) upon perturbation at D2 position. For
convenience, modulus of ∆Entropy (|∆Entropy|), and positive enrichment (∆p > 0, symbol ‘’) and
negative enrichment (∆p < 0, symbol ‘¯’) are indicated. Green bars in the bottom panel are for positions
showing ∆Entropy higher than that of the remaining 80% of the positions (dashed line). The aligned
sequence of PHD (top) is represented by the most frequent amino acid at each position in the 85% nonredundant PFAM sequences. The aligned BAZ2A PHD sequence representing the correspondence between
positions is also shown for convenience. Empty bars are for positions where a gap is the most frequent
symbol for an alignment column. (B) Characteristics of the artificial sequences categorized by entropy
(left) and occurrence frequency (right). For the left panel, only one iteration of the set of 1000 sequences is
shown. The right panel includes 100 iterations of the set of 1000 sequences. The distribution of the
conditional probability in the 100 iterations of the set of 1000 artificial sequences is compared with the
conditional probability (vertical arrow) of obtained from natural sequences. The vertical arrow represents
the conditional probability of the indicated position when perturbed (e.g., the D2 position) while the
horizontal arrows indicate the direction of the deviation of the conditional probability obtained from
artificial sequences from that obtained from natural sequences. The direction of the horizontal arrow also
indicates, positive enrichment (right-hand direction) and negative enrichment (left-hand direction). For
reference, the behavior of Zn-chelating-Cys residue is included to show that highly conserved positions do
not undergo change between natural and artificial sequences. (C) Entropy (left) and ∆Entropy (right) from
the average of 100 iterations show that entropy of a column of aligned artificial sequences is very similar to
that of natural sequences.
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Figure 3.11. E-values and MI of PHD artificial sequences: (A) The –log10 (E-value) of the artificial (top)
and natural (bottom) of PHD sequences. (B) The inter-residue MI values represented in a circular form
along the protein sequence (created by the MISTIC web server) are shown for the artificial (top) and
natural (bottom) sequences. The positions of interest (L2, D2, W etc.) are indicated on the BAZ2A
sequence, while N and C respectively represent the N- and C-terminus of the protein. (C) Comparison of
the inter-residue MI scores between artificial (top) and natural (bottom) sequences.

Peptide Binding-site Hotspot Propensity
Using the pepx95 high-resolution peptide-protein complex structural dataset
(described in Chakravarty et al.)7, we carried out peptide hotspot propensity calculations
following the procedure of London et al46. Briefly, Rosetta in silico alanine scanning
mutagenesis96 was used to estimate the energetic contribution of peptide residue in the
selected peptide-protein complexes. Peptide residues with ΔΔG of 1 kcal/mol or more
were considered hotspots. 270 peptide-protein complexes, where the peptide had at least
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one Arg (in 140 complexes) or one Lys residue (in 130 complexes), were selected for
calculations. The frequency of occurrence (Fr_e) of peptide amino acids when making
large energetic contributions towards overall binding (ΔΔG ≥ 1 kcal/mol) and the
frequency of occurrence peptide amino acids (Fr_b) were used to compute the reference
hotspot propensity ratio (Fr_e/Fr_b) (Figure 3.12B, top). Peptide residue with the
propensity ratio (Fr_e/Fr_b) >1.0 was considered to be a hotspot. Propensity of peptide
amino acids to appear adjacent to an Arg hotspot residue (ARG-Nearness) was calculated
similarly by diving the occurrence frequency of peptide amino acids appearing adjacent
to hotspot Arg residue (i.e. ± 2 residue positions) by Fr_b (Figure 3.12B, bottom).
Frequency of occurrence of Arg hotspot residues was computed considering a 5-residue
stretch spanning ± 2 residue positions on either side of the Arg hotspot residue (Figure
3.12A). Eighty five percent of peptide Arg hotspot residues were observed to be at the
center of sequence segments spanning five residues (Figure 3.12A), while for the
remaining 15%, the Arg residue is either close to the peptide terminus (e.g., H3R2 in
PHD recognition) or is within a motif consisting of less than five residues (e.g., the
WDR5-interacting [Win] –AR– peptide motif)97.
Propensity of protein binding site hotspot residues making non-polar contact with
peptide residues present at ± 2 residues of the peptide hotspot residue (see Figure 3.12C,
right cartoon) was computed in the following way. LIGPLOT98 was used to determine
protein binding-site residues in contact with the peptide ligand. Non-polar carbon atom
contacts were taken from LIGPLOT’s ligand-protein contact list. The frequency of
occurrence (Fr_np) of protein amino acids having non-polar contacts with peptide
residues present at ± 2 residues of peptide hotspot residues (Figure 3.12C, right cartoon)
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that make large energetic contributions (ΔΔG ≥ 1 kcal/mol) was computed. The
frequency of occurrence of protein binding-site amino acids (Fr_pb) was used to compute
the propensity ratio (Fr_np/Fr_pb) (Figure 3.12C). A binding-site residue is one that has
∆ASASC > 0.0 Å2 (see below). A protein Arg residue side chain atom can also have nonpolar contacts using its −(CH2)3− group, and therefore, polar residues can also be present
in Figure 3.12C.
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Figure 3.12. Recognition characteristics of Arg-rich peptides: (A) The frequency of occurrence of peptide
Arg (R) hotspot (rossetta DDG > 1.0) residues in peptides. Fifteen percent of times, the Arg-hotspot residue
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appears close to the peptide terminal or within motifs smaller than five residues, while the remaining 85%
of times it appears at the center of the sequences spanning five residues. (B) The propensity of peptide
hotspot residues (top) and the propensity of residues to appear adjacent to Arg hotspot residue (± 2
residues) (bottom). (C) The propensity of protein hotspot residues (left) making non-polar contacts with
peptide residues adjacent to the peptide Arg hotspot residue (right cartoon). (D) Examples of proteins
(gray) recognizing histone/histone-like Arg-rich peptides (green) where peptide residues with small side
chains (Gly, Ala and Thr) are in contact with bulky nonpolar (light pink) protein residues. Mesh surface
represents the peptide residues with small side chain. Protein name, residue name and the pdb ids are
indicated.

Packing Density, Surface Area and Secondary Structure
We used the Voronoia program99 to compute packing density of atoms. Voronoia
program reports packing density (PD) of an atom as the ratio, PD = VvdW/(VvdW+
Vse), where VvdW is the volume inside the van der Waals sphere of an atom, and Vse is
the remaining solvent excluded volume assigned to each atom99. For PD of a set of
atoms, we average the PDs of the set of atoms of interest. Only high-resolution structures
(resolution ≤ 2.0Å) were considered for packing calculations. The packing density of
atoms varies depending on their distance from the surface100. Therefore, atom depth101
was computed for packing analysis. Atom depth was computed here as the distance from
the nearest surface atom (atoms with non-zero surface area). Reference distribution of
packing density as a function of atom depth (see Figure 3.13) was calculated using the
PISCES102 non-redundant set (≤ 26% sequence identity and resolution ≤ 1.6 Å) of 3700
pdb single chains with size ≥ 50 residues. For discussion of the energetic contribution
residues in the context of PHD scaffold structures, a set of 15 high-resolution (≤ 2.0 Å)
PHD–peptide complexes belonging to different subtypes (Figure 3.2A) and having a low
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sequence similarity with one another (sequence identity ≤ 40%) were chosen. We refer to
the structures of this set for the packing density (PD) discussion of L1, L2 and V
positions. As peptide–protein interfaces have been observed to be very tightly packed,
even more tightly packed than protein–protein interfaces46, we rationalized the
contributions of nonpolar residues at L1 and L2 with respect to interfacial packing.
Having observed the disruptive consequences of substitution of the tightly packed H3A1
residue, the –CH3 group in several PHD–peptide complexes in an earlier study7
encouraged us to look in a similar manner at interfacial nonpolar group packing in
BAZ2A proteins.
NACCESS103 program was used to compute the accessible surface area (ASA).
The amount of surface area lost by the side chain atoms of a protein residue upon
formation of a peptide–protein complex is measured by ΔASASC. ΔASASC of the ith
residue is, ΔASASC_res_i = (residue_i_ASASC_protein) – (residue_i_ASASC_complex)
where residue_i_ASASC_protein and residue_i_ASASC_complex are respectively the side
chain atom surface area of the ith residue in the free and bound form of the protein.
Protein residues with ΔASASC ≥ 10Å2 are considered to make contact with the peptide
(Figure 2.14A). ΔASASC of protein hotspot residues (Figure 3.14) is also computed this
way. Assignment of the secondary structural elements (SSE) of coordinate files was
carried out using the SEC-STR program104, and the SSE symbol ‘G’ was taken as the 310helix. Amino acid frequencies of segments with 310-helix conformation were used to
check the preference of Asp residues within the 310-helical segments of the PISCES102
non-redundant set.
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Peptide Swapping and Peptide Backbone Clash
Using the MUSTANG85 structural alignment (Figure 3.2A), the coordinates of one
PHD–peptide complexes were superposed and then transformed onto another. For
convenience, we use one PHD–peptide complex as a reference, and the remaining
complexes are superposed onto the reference molecule. After coordinate transformations,
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the peptide coordinates of one complex are then placed onto another. For example, the
peptide coordinates of the transformed NSD3-PHD complex are placed onto transformed
coordinates of KAT6A-PHD2. We refer to this as peptide swapping. This is a simple but
a crude approach, as it does not optimize backbone hydrogen bonding. The extended
conformations of peptides in the PHD_nW subtype (2puy, 4gne, 4qbs and 3qla) were
placed onto the PHD_nW_DD subtype (4q6f, 3asl, 5b75 and 5i3l). PHD–peptide intermolecular backbone carbon–carbon contact distances for H3 residues 4-7 were
determined using LIGPLOT98 (Figure 3.21D). As a positive control, peptides in the
PHD_nW subtype (2puy, 4gne, 4qbs and 3qla) were swapped among themselves for a
rough estimate of the error (~16%) contributed by the crude swapping approach
(Figure 3.21C). As PHD sequences of these complexes share < 40% sequence identity,
comparison of results obtained by swapping between subtypes (e.g., PHD_nW and
PHD_nW_DD) and those within a subtype (e.g., PHD_nW) was acceptable.

RESULTS AND DISCUSSIONS
Binding energetics of the BAZ2A PHD finger in the context of the PHD superfamily
Though diverse sequences populate this family, PHD finger sequences can be
grouped into two major functional subtypes7: (i) the PHD_W subtype and (ii) the
PHD_nW subtype (Figure 3.7). The justification for this grouping is that functionally
related positions show enrichment in specific residue types among the subtype sequences;
e.g., aromatic cage-forming positions are enriched with aromatic residues in the PHD_W
subtype7. Positions in the PHD finger superfamily corresponding to the BAZ2A PHD
were similarly checked for residue-type enrichment. The overall result for the occurrence
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frequency and residue enrichment at the L1 and L2 positions of the PHD superfamily is
represented as sequence logos in Figure 3.15. It is clear that bulky nonpolar residues (Ile,
Val, and Leu) are always present at the L1 position irrespective of the subtype; i.e., p =
0.95 is observed for the entire superfamily (Figure 3.15A, B). However, this is not the
case for the L2 position, as the occurrence frequency of bulky nonpolar residues is
progressively enriched (0.32 → 0.51 → 0.82) as one moves from the superfamily level to
specific subtypes (Figure 3.15B). Interestingly, the value of p for the bulky nonpolar
residues at the L2 position in PHD_W subtype sequences is negligibly small (p = 0.05).
The PHD treble clef knuckle xCDxCDx sequence pattern mentioned above refers to the
PHD_nW_DD subtype, which includes the BAZ2A PHD, KDM5B PHD, UHRF1 PHD,
KAT6A DPF, and DPF3 DPF domains. A bulky nonpolar residue at L2 seems to be a key
feature of the PHD_nW_DD subtype. As a control, we also checked the xCDxCDx
motif-containing sequences (e.g., TAF3 PHD, DIDO PHD) in the PHD_W subtype, and
we observed that they never include bulky nonpolar residues (p = 0.03) at L2
(Figure 3.15B), suggesting that PHD_nW_DD is likely to be a distinct subtype. In other
words, in addition to having the pair of Asp residues in a treble clef knuckle, the
PHD_nW_DD subtype likely has additional features, such as a bulky nonpolar residue at
L2. To confirm the energetic contribution of residues at L2 for the PHD_nW_DD
subtype, we also mutated bulky nonpolar residues to Ala at the L2 position in hUHRF1
PHD (M345A), hKDM5B PHD (L326A), and hKAT6A DPF (F280A) domains (Figure
3.16A and see Figure 3.2 alignment). The L2 position mutants of the hUHRF1 PHD,
hKDM5B PHD, and hKAT6A DPF did not show any detectable peptide binding
according to ITC (Figure 3.16A), suggesting that substitution of the bulky nonpolar
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residues completely disrupted peptide binding. This suggests the importance of the
energetic contributions of bulky nonpolar residues at the L2 position in the
PHD_nW_DD subtype. The sequence identity distribution within subtypes (Figure 3.7B)
suggests that, although the median value increases from the superfamily level to the
PHD_nW_DD subtype, there are diverse sequences in the PHD_nW_DD subtype. For
example, the hBAZ2A PHD, hUHRF1 PHD, and hKAT6A PHD2 share less than 40%
sequence identity with each other. Yet these members retain similar peptide-anchoring
residues, indicating a similar binding mechanism and therefore providing a reason to
select them for the subtype study.
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Figure 3.15. PHD subtypes, and L1 and L2 enrichment: (A) PHD topology cartoon (left) showing the
strand that augments the peptide (green) harboring the L1 and L2 positions. Sequence logo (right) showing
strand-knuckle-strand segment of the PHD fold with the secondary structural elements on top. The
occurrence frequency of bulky nonpolar residues at L1 and L2 positions is below the logo. (B) Sequence
logo of the two major PHD subtypes, PHD_W (left) and PHD_nW (right). Structures of representative
members of these subtypes are adjacent to the logo showing the characteristic key residues in stick (light
pink). The lower panel (shown with arrow) indicates logo of sequences extracted from the two respective
subtypes with the knuckle having xCDxCDx sequence pattern. The occurrence frequency of bulky
nonpolar residues at L1 and L2 positions is similarly below the respective logos. The pdb ids are in
brackets, and convenience H3C4 atom in TAF3 PHD is represented as N (blue).

Justifying the contribution of the L1 position
For the BAZ2A complex, the L1692 Leu CD1 atom is in van der Waals contact
with the H3A1 residue –CH3. The packing density of the BAZ2A L1692 Leu CD1 atom
in the BAZ2A complex is observed to be higher than what is typically observed for the
Leu CD1 atom at similar distances from the protein surface (Figure 3.16B), justifying the
role of the L1692 side chain in tightly anchoring the H3A1 residue –CH3. The packing
density of the BAZ2A L1692 Leu side chain atoms in the complex is 0.62. Irrespective of
the PHD subtype, L1 residues (p = 0.95) in the 15 PHD–peptide complexes are also in
van der Waals contact with the H3A1 –CH3 functional group. The average side chain
packing density (0.623 ± 0.032) of nonpolar L1 residues in these complexes suggests that
the L1 residues are packed very similarly as in the BAZ2A complex (Figure 3.16C). The
similarity between H3A1–CH3 anchorage by BAZ2A L1692 and by the L1 residue in the
rest of the complexes can further be appreciated by noting that ΔASASC for the L1
residue in 15 complexes (17.15 ± 4.4 Å2) is close to that of BAZ2A L1692 (~15 Å2). In
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other words, despite low sequence identity, diverse members of the PHD superfamily
utilize the L1 nonpolar residue in nearly identical fashion in anchoring H3A1–CH3, and
its substitution thus likely leads to a poorly packed interface, resulting in the disruption of
the complex. The replacement of L1 nonpolar residues to Ala in the BAZ2A, UHRF1,
KAT6A, and KDM5B (Figure 3.16A) PHD fingers therefore severely compromises
peptide binding. In the recently acquired structures of the zf-CW domains105, 106 (e.g.,
MORC3, ZCPWP2, and ZCPWP1) in complex with the histone H3K4me3 peptide, one
also observes that H3A1–CH3 (Figure 3.2C) is in van der Waals contact with a highly
conserved nonpolar residue (p = 0.80) in the zf-CW scaffold, located at a position
corresponding to that of the PHD L1 position (Figure 3.2B–D). As both PHD and zf-CW
domains require the peptide NH2-terminal for backbone-mediated hydrogen bonding, it is
interesting to note that both have adopted very similar mechanisms for anchoring the
terminal Ala –CH3 group by utilizing a nonpolar L1 residue (Figure 3.2B–D). These
observations are also important in the context of histone reader reengineering.
Reengineering the PHD and zf-CW domains for effectively reading marks other than at
the H3-terminal would most likely require manipulation of the L1 position.
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of the forward binding reaction is shown (as -DGo) for the three readers, hKDM5B PHD (top), hUHRF1
PHD (middle) and hKAT6A DPF (bottom). For convenience of comparison, BAZ2A mutants are shown at
the bottom. Residues that contribute more than 1 kcal/mole of free energy are below the dotted line. Red
bars are for positions where binding was not detected in ITC experiments. (C) Distribution of packing
density of Leu-CD1 atom (top) in proteins within the shell of 3.5 – 5.5Å from the protein surface, and the
packing density of BAZ2A L1692 CD1 (red dashed line) within similar distances from the surface in the
BAZ2A complex. Surface mesh (bottom) representing the contact between H3A1-CH3 and L1 position in
BAZ2A. (D) Surface mesh representing the contact between H3A1-CH3 and L1 position in different
subtypes. In the mesh representations, protein carbon atoms are in light pink and peptide carbon atoms are
in split pea color.

Justifying the contribution of the L2 position
In a similar manner, we then looked at the BAZ2A PHD L1693 residue. The CD1
and CG atoms of this residue (L2) are in van der Waals contact with the histone H3 Thr3
backbone C atom (Figure 3.18B). Moreover, the packing density of the CD1 and CG
atoms of this residue in the BAZ2A complex is similarly found to be higher than
typically observed for other Leu CD1 and CG atoms at their respective distances from the
surface (Figure 3.18A), and their contacts with the peptide backbone C atom maintain a
well-packed environment for the PHD–peptide complex. The structural changes for the
BAZ2A L2 position upon peptide binding are, however, different from those at the L1
position. The ΔASASC values for the L1 and L2 positions are ~20 Å2 and ~55 Å2,
respectively, for BAZ2A (Figure 3.14). A value of 20 Å2 for ΔASASC of a hotspot
residue is, however, far less common (ASA ≅ 20 Å2, Figure 3.14). A more common
scenario for protein hotspot residues is the one observed for the L2 position, where the
residue is nearly fully exposed and then undergoes a large change in surface area while
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contributing to tight interfacial packing. The change in packing density (ΔPD) of the
BAZ2A L2 side chain atoms is 0.16, while that of those at the L1 position is 0.08. Similar
to the BAZ2A L1693 residue, bulky nonpolar residues at the L2 position in UHRF1
(M345), KAT6A (F280), and DPF3 (F333) complexes pack against peptide backbone
carbon atoms (Figures 3.17A, 3.18B). In general, in the PHD_nW_DD subtype, L2
residue side chain atoms contribute toward tightly packing the peptide backbone atoms.
This is in contrast to the contacts made by L2 residues in other subtypes. In the PHD_W
subtype, L2 residues, with smaller side chains (e.g., Gly, see Figure 3.2A), are typically
not in contact with H3 peptide backbone atoms (Figure 3.18C). Based on the side chain
size, the PHD_nW subtype members may or may not retain contacts with the peptide
backbone (Figure 3.17B). The side chain packing density of L2 residues in the three
subtypes, 0.520 ± 0.045 (PHD_W), 0.542 ± 0.029 (PHD_nW), and 0.572 ± 0.038
(PHD_nW_DD), also shows a trend of enhancing packing for residues at L2 in the
PHD_nW_DD subtype. In short, backbone contacts by the L2 residue are likely to
contribute in a subtype-specific manner.
Why should there be a need for a contribution from the L2 residue in a subtypespecific manner? We will try to rationalize the answer for this in the following.
Anchorage of the peptide side chain H3Lys4 quaternary ammonium ion
(–CH2N+(CH3)3) by the PHD aromatic cage and the terminal H3A1–CH3 by the PHD L1
likely dominate the peptide-binding energetics in the PHD_W subtype (Figure 3.17C).
Salt bridge-mediated H3Lys4 and H3Arg2 anchorage and H3A1–CH3 anchorages by L1
likely dominate the binding energetics in the PHD_nW subtype (Figure 3.17C). For the
PHD_nW_DD subtype, we had earlier discovered that peptide binding might not require

99
an energetic contribution from the H3Lys4 residue7. The lack of energetic contribution
from the H3Lys4 residue must be compensated by additional contacts, such as those
made with bulky L2 residues. Thus, the L2 contribution is likely to be an essential feature
for peptide binding in the PHD_nW_DD subtype, as we showed that substitutions of
bulky L2 residues with Ala in the BAZ2A, KDM5B, UHRF1, and KAT6A proteins
(Figure 3.16A) completely disrupt peptide binding for all of them. Other subtypes may
not require L2 contacts (p ≅ 0.05), as they have other strong, specific, peptide-anchoring
contacts and thus can afford to have residues with smaller side chains (e.g., Gly) at the L2
position. Inspecting the alignments and structures of the PHD_nW subtype, one observes
that the DNMT3A ATRX–DNMT3–DNMT3L (ADD) domain retains the bulky nonpolar
L2 residue, but the ATRX and AIRE proteins do not (Figures 3.2A, 3.17D). It is
interesting to note that the treble clef knuckle Asp residue forming a salt bridge with
H3R2 is absent in the DNMT3A ADD domain but is present in the ATRX and AIRE
proteins (Figure 3.2A, 3.17B). For AIRE, substitution at the L2 position (C310L) by
introduction of a Leu residue enhances affinity for the unmodified H3 peptide by ~15
fold (Figure 3.18D). A gain in free energy (ΔΔG) of ~1.5 kcal/mol could compensate for
the loss of another interaction of similar strength. It is thus temping to speculate that the
loss of one type of contact is likely to be compensated by another, such as the L2 contact.
However, these speculations will need to be confirmed by detailed experimentation as
part of a further investigation.
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Figure 3.17. L2 contacts in other subtypes: L2 contacts in DPFs (A) and PHD-nW (B). (C) Anchor points
in in different subtypes are represented by double headed arrow. (D) A symbolic representation of
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adjustments due to position specific residue substitution. A red ‘capsule’ represents absence while the
arrow (dashed line) indicates presence of a specific residue at the same site.

FIGURE 4
A
45

B

D

Leu CD1
(Depth 0.5Å)

T3

kcal mol-1 of injectant

30

L1693

L2

15

45

0.2

L2
0.0

H3
L1693 CD1

0

Frequency (%)

BAZ2A-L1693

0.4
0.6
Packing Density

BAZ2A-PHD

0.8

Leu CG
(Depth 2.5Å)

H3

T3

PHD_nW_DD

Frequency (%)

L2

L1693 CG

7

-8.0

6

WT

5

Kd = 24.60 μM
Kd= 1.54 μM

WT C310L

0.0

0.5

1.0
1.5
Molar Ratio

2.0

2.5

L2

BAZ2A SVNKVTCLVCRKGDNDEFLLLCDGCDRGCHIYCHRPKMEAVPEGDWFCTVCLAQQV
AIRE ---EDECAVCRDGD-G-ELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQA--

WT

15

0.8

Mutant (model)
H3

M345

C

8
ΔΔGo = 1.0

-12.0

L2

0.4
0.6
Packing Density

C310L

-4.0

L

30

0.2

AIRE C310L

AIRE-PHD1

T3

H3

C310

UHRF1-PHD

T3

L310

AIRE-PHD1

PHD_W
T3

T3

T3
H3

G201
C22

Q1587

L2
L2

DIDO1-PHD

L2

ING5-PHD

MLL1-PHD3

Figure 3.18. L2 mutations in PHD_nW_DD subtype: (A) Packing density of BAZ2A L1693 CD1 (top) and
CG (bottom) are shown as red dashed lines among the distributions of Leu CD1 and CG atoms respectively
within the indicated shells in protein structures. (B) Surface mesh representing the contact between BAZ2A
L1693 side-chain and the peptide backbone (top) and similar L2 contacts for UHRF1 (bottom). (C) Mesh
surface representations of the L2 contacts in PHD_W subtype for comparison. (D) ITC titration profiles of
the wild type and L2 (C310L) mutant of AIRE PHD with histone H3-1-11 peptide. Mesh coloring is same
as that in Figure 3.16.
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Other nonpolar residue contributions at the interface of BAZ2A and the Subtype
Substitution of V1713 to Ala in BAZ2A (Figure 2.14, Table 2.8) also weakens
peptide binding (ΔΔG = 1.1 kcal/mole). BAZ2A V1713 is in contact with histone
H3Thr3–CH3 (the CG1 atom) and thus contributes to packing with the Thr3–CH3 group
(Figure 3.19B, C). We similarly observed the enrichment for nonpolar residues at a
position corresponding to BAZ2A V1713 (Figure 3.19B); e.g., the occurrence frequency
is enhanced (0.38

0.64) in the PHD_nW_DD subtype (Figure 3.19B). However, the

packing density of the V1713 side chain atom (Figure 3.19C) in contact with the peptide
is lower than that observed for the L1 and L2 atoms. This is also consistent with the
observation that the energetic contributions of L1 and L2 towards peptide binding are
greater than that of V1713, suggesting that the tighter the packing, the larger the energetic
contribution to be expected. Interestingly, the enrichment at this position is smaller than
at the L2 position (0.32

0.81) and is also consistent with its respective energetic

contribution. For the PHD_nW_DD subtype, however, it is interesting to note that,
despite low sequence identity, BAZ2A, UHRF1, and KAT6A PHD2 have near-identical
structures in this region (Figure 3.19B). Thus, the observed occurrence frequency of
nonpolar residues in a position corresponding to that of BAZ2A V1713 in this subtype is
more reliable than that of the PHD_W subtype, which includes insertions/deletions in this
region (Figure 3.19B). We therefore believe that it is a subtype-specific adaptation to
strengthen the anchorage of H3T3–CH3, as UHRF1 V365 and KAT6A M300 are also in
van der Waals contact with H3T3–CH3, like BAZ2A V1713 (Figure 3.19D). This is also
consistent with an earlier observation that substitution of H3Thr3 to Ala severely
compromises peptide binding in BAZ2A and KDM5B7. With respect to PHD reader
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contact with the peptide, the contribution of H3Thr3 CH3 (CG1 atom) is anticipated to
be different from that of the OH group (OG1 atom) for the observed effects of the H3
(Thr

Ala) 3 substitution. This is further substantiated by the recently obtained DPF

structures of KAT6A24, 81 and DPF3106, in which H3Thr3–OH is engaged as the N-cap107
for the peptide helix, while H3Thr3–CH3 is oriented towards the enriched nonpolar
residue side chain (Figure 3.19D). Thus, enrichment of multiple nonpolar residues
(including Pro, L2) at specific positions is observed in the PHD_nW_DD subtype, which
shows a strong preference for contacts with the H3Thr3 backbone (L2) and side chain
atoms. As discussed above, a gain in specific contacts is likely to be a compensatory
adjustment for the loss of another contact, and the PHD_nW_DD subtype is enriched
with residues for making contact with the first three H3 residues (H3A1-T3) at the
expense of other contacts. Tracing the orthologs of human PHD fingers, it had earlier
been noted that KDM5B PHD and UHRF1 (of the PHD_nW_DD subtype) are likely
among the early “inventions” of the PHD7. Among the orthologs of the KDM5B PHD,
tracking the positions that show a gain in specific contacts with the peptide suggest that
anchoring histone H3 by the first three residues (H3A1-T3) could have been an early
adaptation by utilizing position-specific nonpolar residues (Figure 3.20A). The DPFs, in
addition to these features, also extended their contacts with H3 well beyond the H3-1–3
residues by utilizing the non-canonical surface of the PHD1 of the DPFs24, 81, 106, 108, 109.
Enrichment of multiple nonpolar residues among histone readers was also observed
earlier; e.g., the histone H3K9me3 and H3K27me3 readout by the chromodomains of
human CBX paralogues110. CBX2, -4, -6, -7, and -8 retain a pair of position-specific
clasping nonpolar residues at the peptide binding site (Figure 3.20C) in place of a pair of
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clasping negatively charged residues in the corresponding positions in CBX1, -3, and 5110. Cbx1, -3, and -5 bind peptides with a higher affinity and are more specific for
H3K9me3. By contrast, CBX2, -4, -6, -7, and -8 bind peptides with lower affinity and
poorly discriminate between H3K9me3 and H3K27me3110. Thus, the nonpolar residues in
the CBX example contribute to lowering affinity and specificity. The packing density of
the CBX2 binding-site nonpolar residue (V11 and L50) side chain atoms in complex with
the H3K27me3 groups (Figure 3.20C) are only 0.39 and 0.43, respectively, which are
much lower than at the L1, L2, and V positions of PHD_nW_DD. The enriched nonpolar
residues observed here certainly contribute to strengthening specific interactions due to
tight packing and thus are distinct in behavior from those of the CBX example.
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Figure 3.19. Enrichment at other positions: (A) The sequence logo (right) of the segment of interest
(dashed line in the topology cartoon, left). (B) Sequence logo of the same segment respectively of PHD_W
(top, left), PHD_nW (top, right) and PHD_nW_DD (bottom, right) subtypes. Structures of the segment of
interest in PHD_nW_DD subtype (bottom, right). Occurrence frequency at the positions of interest is below
the logo, and the pdb ids of the proteins are in Figure 3.2. Side-chains of position in BAZ2A that are
enriched in this segment are highlighted with sticks (light-pink) in the structures (bottom, right). Structures
of the segment of interest in PHD_W subtype structures (bottom, left). The segment of interest indicated in
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(A) is similarly indicated with a circular dashed line. (C) Packing density of BAZ2A Val-CG2 atom is
compared with that of Val-CG2 atom (reference) within similar distances from protein surface. (D)
Orientations of H3Thr3-CG2 and H3Thr3-OG1 atoms in UHRF1 (left) and KAT6A (right). Light pink and
green curved lines represent non-polar contacts. ‘N-cap’ hydrogen bonded capping of helix N-terminus.
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Figure 3.20. KDM5B orthologous sequences and other nonpolar contacts: (A) Tracing BAZ2A residues
(light pink) in contact with H3 peptide among the KDM5B orthologs. (B) Residue contacts of histone
H3Thr3-CH3 in the PHD_W subtypes. The PHD_W subtype may or may not retain contacts with H3Thr3-
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CH3. (C) The pair of clasping residues of human CBX chromodomain proteins at the histone peptidebinding site.

Contributions of negatively charged residues at the interface of the Subtype
As the PHD_nW_DD subtype is characterized by the presence of a pair of Asp
residues (in the xCDxCDx motif), we wanted to understand the contributions of the
BAZ2A D1695 (D1 position) and D1698 (D2 position) residues in the context of subtype
structure. The substitution of D1695 severely compromises binding, consistent with the
observed effects of D1 substitution in the UHRF119, KAT6A81, and KDM5B7 proteins.
The side chain carboxylate at D1 is engaged in a salt bridge-mediated interaction with the
H3Arg2 residue. The complete loss of binding upon D1695 substitution is expected, due
to the loss of the electrostatic interactions between D1695 and H3Arg2, and thus D1695
has a very large energetic contribution, similar to that of the D1 positions in UHRF1,
KAT6A, and KDM5B. ΔΔG for BAZ2A D1698 (D2 position) is 0.67 kcal/mole (Figure
2.14B). ΔΔG for substitution of Asp residues at the D2 position in UHRF1 and KDM5B
are 1.61 and 1.23 kcal/mole, respectively (Figure 3.16A, B). For KAT6A, we expect the
energetic contribution of D2 to be as large as we observed for complete disruption of
binding upon D2 substitution. In short, the D2 position also has a substantial contribution
(ΔΔG >> 1.0 kcal/mole) in anchoring the H3R2 residue for the PHD_nW_DD subtype.
This also justifies PHD finger sequence grouping by the treble clef knuckle xCDxCDx
pattern for subtype-specific analysis, in which the Asp residues are expected to serve as
binding hot spots. For the BAZ2A PHD, however, the contribution of D1698 (D2
position, 0.67 kcal/mole) is less than that of the D2 position in other members as
mentioned in chapter 2. A structural deviation of the treble clef knuckle xCDxCDx
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pattern in the BAZ2A PHD is observed (Figure 2.16). In comparison with what is
typically observed in other PHD fingers, the structural deviation of the knuckle places
BAZ2A D1698 farther away from the H3Arg2 residue. This structural deviation is also
reflected in the loss of surface area upon complex formation. The ΔASASC of BAZ2A
D1698 is 0.0 Å2 (no H3R2 contact), while that for the D2 positions in the UHRF1,
KAT6A, and DPF3 complexes is 17.14 ± 2.55 Å2. The smaller contribution of D1698 is
likely due to the smaller contact (enlarged inter-residue distance) in the BAZ2A complex.
The D1 ΔASASC (in BAZ2A, UHRF1, KAT6A, and DPF3) is 34.90 ± 3.93 Å2, while
that of D2 is 17.14 ± 2.55 Å2. The amount of contact between the oppositely charged
groups is also consistent with the larger energetic contribution of the D1 position to
peptide recognition in the PHD_nW_DD subtype.
We then focused on the contributions of the acidic patch38 residues of BAZ2A.
However, substitution of acidic patch residues to Ala (D1688A, E1689A) did not indicate
whether they might contribute to the energetics of peptide binding. We actually observed
a slightly more negative ΔG of binding for these mutants (Table 2.8A). We therefore
focused on the structural contributions of the acidic patch, consistent with the recent
structural report on the BAZ2A PHD (pdb code 5t8r)38. For the available PHD_nW_DD
subtype structures, the conformation of the acidic patch segment is observed to be a 310helix (or consecutive turns, Figure 3.21B). Early conformational analysis111 showed that
the occurrence frequency of Asp residues within the first three positions of the 310-helix
or turns are higher than for other amino acids (Figure 3.21B, bottom). The enrichment of
negatively charged residues at the acidic patch for the PHD_nW_DD subtype thus
suggests that the sequences of this subtype likely retain a 310-helical conformation. The
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sequences of other subtypes prefer Gly for the corresponding segment, and the
conformation of this segment in other subtypes is distinctly different from a 310-helix
(Figure 3.21C). These observations therefore suggest a structural, rather than an
energetic, role for the acidic patch residues. The adoption of the 310-helical conformation
by the acidic patch has a consequent impact on the cognate peptide conformation (Figure
3.21C). The peptide, in the PHD_W and PHD_nW subtypes, is typically accommodated
by β augmentation. However, the strand conformation, beyond residue number 4 of H3,
will likely “clash” with the 310-helical conformation of the acidic patch (Figure 3.21D).
Therefore, it is tempting to believe that the H3 peptide adopts a helical conformation in
order to evade clashes with the acidic patch. Histone H3 thus adopts a context-dependent
conformation consistent with earlier structural observations (Figure 3.9), and a few
sequence features of H3 likely contribute to adopting a helical conformation. They are:
(a) the N-cap H3T3-OH107, (b) H3G11, a helix-terminating Gly112, and (c) the K9
positive charge for accommodating the helix dipole113 (Figure 3.21D). As we observed
the N-cap role of H3T3-OH with other H3 readers (Figure 3.9), the H3T3ph mark in
these readers would impede H3 helix initiation. These readers would thus not be suitable
candidates for redesigning as H3T3ph readers. Overall, we observed distinct roles of the
pairs of acidic residues for the PHD_nW_DD subtype as: (a) treble clef knuckle acidic
residues anchoring H3R2 and (b) acidic patch residues influencing H3 conformation.
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Figure 3.21. BAZ2A PHD treble clef knuckle Asp pair: (A) Structural deviation and distances between
oppositely charged atoms among the PHD_nW_DD subtype structures (left), and the treble clef knuckle
Asp residues pair in UHRF1 (top, right) and KAT6A (bottom, right) anchoring histone H3-Arg2 residue.
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(black bar, below) expected for PHD_nW_DD (right) when interacting with the strand conformation of H3.
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(D) Symbolic representation of the context dependent folding of H3 peptide upon interaction with
PHD_nW_DD (top), and the helix punctuating features of N-terminal H3 (bottom).

Mutual information between residues at the BAZ2A interface and Subtype
The observed enrichment of nonpolar residues around the peptide-binding site
encouraged us to further probe the relationship between the treble clef knuckle Asp pair
and the enriched residue positions in the PHD_nW_DD subtype. We examined the
following two relationships first: (a) the enrichment in artificial sequences and (b)
reciprocal enrichment. For the enrichment analysis, artificial PHD finger sequences were
generated with E-values consistent with that of natural PHD sequences (Figure 3.11A)
and with characteristics similar to that of the PFAM master alignment (Figure 3.10C).
Enrichment analyses carried out with the artificial sequences clearly show that results
differ from those observed with natural sequences (Figure 3.10B, right). For example,
positive enrichment of the L2 position (p = 0.31

0.63) when the D2 position is

perturbed in natural sequences is very different from the distribution of L2 position
enrichment probabilities observed with artificial sequences for D2 perturbation (Figure
3.10B, right). This observation suggests the nonrandom nature of the enrichment
observed here. For reciprocal enrichment, we wanted to check whether the D2 position
would similarly show positive enrichment (Δp > 0) if other nonpolar residue positions
(e.g., the L2 position) were perturbed (Figure 3.9A). Asp was enriched at the D2 position
when other peptide-anchoring positions were perturbed in natural sequences (Figure
3.9A). Like the D2 positions, other peptide-anchoring positions were also checked to
determine whether there is a mutual relationship among a set of positions in the PHD
superfamily fold (Figures 3.9A, 3.7D).
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Although enrichment analysis is simple with respect to computation, it may lack
mathematical rigor and be unable to distinguish stochastic relationships from real ones.
Therefore, we applied mutual information (MI) theory to probe the relationship between
the peptide-binding positions of PHD fingers. This was motivated by the earlier
observation that a set of PDZ peptide binding-site positions (5–6 positions) was observed
to have higher MI, and these residues were concluded to be coevolving45. Using the
MISTIC89 server, we estimated the MI for every residue pair in the PHD PFAM
alignment positions (Figure 3.9B). Many of the residue pairs showing mutual enrichment
(Figure 3.9A) have MI scores that are much higher than the rest of the PHD residue pairs
(Figure 3.9B). The MI behavior of PDZ-binding residues was also estimated (Figure
3.22A) for comparison. Despite differences in the construction of the dataset and
approach from the earlier study45, it was interesting to observe that residue pairs
consisting of only 5–6 positions (Figure 3.22A) show MI values well above the rest, as
reported earlier. Our approach is thus acceptable, and the MI behavior of enriched PHD
binding-site residues is comparable to that of the PDZ domain (Figure 3.22A). It is
therefore tempting to believe that PHD binding-site residues (at the L2, D2, G/W, AP2
positions) are also coevolving like the PDZ binding site45. With regard to coevolving
binding-site residues, the similarity between the PHD and PDZ domain can further be
appreciated by considering the following. Like ADD redesign (for switching peptide
specificity)28, 29, desirable substitutions at the coevolving PDZ binding-site positions can
also switch peptide specificity: e.g., in redesigning Tiam1 to behave like Tiam2114. Thus,
identification of coevolving positions can also be useful for subtype switching.
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Cumulative MI (CMI), reported by the MISTIC89 server, represents the degree of
participation of a position in the mutual information network91. For the PHD finger, the
W/G position has the highest CMI value (Figure 3.9B), as the position shows a strong
negative enrichment compared with many other nonpolar residue peptide-anchoring
positions (Figure 3.9A), and the W/G position also shows a positive enrichment for
aromatic cage residues7. Therefore, using the W/G position to partition the PHD finger
sequences as a first step in PHD subtype analysis (see Figure 3.15) is justified. The L2
position also has a large CMI value, suggesting its contribution in PHD subtype
classification. However, artificial PHD sequences (see above) do not show a positional
correlation (Figure 3.11B, C).

Figure 3.22. Mutual Information of the PDZ binding site: (A) MI score of PDZ binding-site positions
(right) with the residues mapped on the INAD_DROME PDZ structure (left). Only 18 binding-site
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positions (left) mapped on the structure are analyzed for MI (right). Seven positions with higher interresidue MI value are indicated in gray on the structure (left, e.g. S27, F28, I30 etc.) and their MI values are
indicated with ‘¯’ arrow on the MI histogram. Protein name and pdb id are indicated. (B) A part of the 85%
non-redundant PFAM alignment of PDZ domains used for MI calculation shows the positions of the seven
binding site positions for convenience. The double-headed arrows indicate interacting positions. (C)
Reciprocal enrichment for some of the selected binding-site positions.

GREMLIN distance restraints and RMSD
Mutual information extracted from multiple alignments to infer coevolution by
correlated mutation has recently been successful in protein structure prediction87, 88, 115,
116

. In other words, the correlation between alignment positions can provide distance

restraints for folding the polypeptide chain representing a protein family87, 88, 115, 116. The
PHD finger binding-site positions that we found to be correlated are likely to be
correlated for biochemical function (e.g., peptide binding) rather than for the folding of
the PHD scaffold. With GREMLIN87, 88 pre-computed distance restraint scores for PFAM
domain residue pairs, we wanted to check the scores of PHD finger positions that are
related by function (e.g., L2–D2 or L2–W pair positions, Figure 3.9B). GREMLIN
distance restraint scores for these functionally related positions are actually observed to
be much higher than the rest of the pairs (Figure 3.9B), even though these residues are
not in van der Waals contact with each other. Physically interacting positions that
contribute to folding are expected to coevolve as a mechanism for compensating the
replacement of interacting partner residues. In the PHD example, the restraint score does
not seem to distinguish between pairs physically interacting with one another from those
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related by function. The pre-computed GREMLIN score therefore, encouraged us to
experimentally probe the roles of the correlated binding-site positions by mutagenesis.
A comparison of the RMSD of crystal structures (≤ 2.2 Å) of PFAM domain members
sharing less than 40% sequence identity shows that the structural deviation of the PHD
peptide binding-site is smaller (Figure 3.23B). The implication is that this smaller
structural deviation may be useful in design applications. The introduction of desired
substitutions at coevolving binding-site positions would likely confer small structural
perturbations and thus enable achieving the expected outcome without having to carry out
extensive optimization of the rest of the scaffold, e.g., repurposing of the ADD
module28, 29.
Here we were also able to enhance the affinity of the AIRE PHD (~15-fold lower
Kd) by merely incorporating a desired substitution at a coevolving position showing a
very small structural deviation (e.g., L2 in Figure 3.23C). In addition to altering affinity
and specificity, sequence-based subtype classification can also benefit from the observed
small structural deviation. As the rest of the PHD sequence positions show larger
structural deviations (Figure 3.23B), inclusion of non-binding site sequence positions in
subtype classification may not provide reliable groupings. For example, an earlier
study117 on PHD finger classification, using the full-length PHD sequence had grouped
BAZ2A (and BAZ1A, BAZ1B, BAZ2B) with AIRE (and TIF1A, CHD3_1, CHD3_2,
PF21A), while MYST DPFs were placed in a separate group. As observed in an earlier
work7, the binding behavior of BAZ2A, a PHD_nW_DD subtype, is distinct from that of
AIRE, and we found that DPF binding behavior is similar to PHD_nW_DD. Thus, our
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experiments suggest that grouping based on a set of coevolving binding-site residues,
especially showing small structural deviations, would likely be more reliable.
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Figure 3.23. GREMLIN score and RMSD of peptide binding sites: (A) GREMLIN s-sco score mapped on
to the structure of PHD (left), PDZ (middle) and Bromodomain (right). (B) Structural deviation (RMSD)
between corresponding positions among X-ray structures (resolution ≤ 2.2Å) of a superfamily sharing less
than 40% sequence identity. The color ranges between black (RMSD = 0.0 Å) to white (RMSD = 3.5Å).
PHD positions are indicated on the structure. (C) Mean and SD of the corresponding position’s Cα-Cα
atom distances for the binding- site coevolving positions. (D) Alignment between GREMLIN consensus
sequence and the protein sequence is presented for the convenience of mapping the s_sco score on the
structure.

Characteristics of Arg-rich peptide recognition
Histone peptides are rich in positively charged residues, and therefore the
observation of enriched nonpolar residues making significant energetic contributions to
histone peptide recognition encouraged us to further determine the recognition
characteristics of peptides rich in Arg and Lys residues. Using Rosetta alanine-scanning
mutagenesis96 on the dataset of peptide−protein complexes used in an earlier work7, we
computationally probed peptide-recognition characteristics. Peptide hotspot propensity
scores computed using this dataset also show strong preferences for W, F, I, L, Y, and R
(propensity score > 1.0), and some of the remaining (disfavored) amino acids have scores
<0.75 (Figure 3.12B). Therefore, for the analysis we focused on peptide Arg hotspot
residues (Figure 3.12B). ARG-Nearness, the preference of an amino acid to be adjacent
(± 2 positions) to the peptide Arg hotspot residue was also computed (Figure 3.12B). The
ARG-Nearness propensity score is quite different from that of the reference peptide
hotspot scores (Figure 3.12B). For example, irrespective of side chain size, the ARGNearness propensity scores of several amino acids are close to 1 (Figure 3.12B); i.e.,
amino acids with even small side chains (e.g., G, A, or T) are thus not disfavored to be
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near an Arg hotspot residue in peptide−protein complexes. This is important, as the
presence of amino acids with small side chains adjacent to Arg residues is common
among histone-tail sequences. For comparison, Arg in the kinase-docking D motifs is
close to one or more bulky nonpolar residues118, 119. Therefore, to better understand
nature’s design principles, we wanted to know whether there is a preference for amino
acids (at the peptide binding site of a protein, e.g., L1 or L2) for making contact with
residues with small side chains adjacent to peptide Arg hotspot residues (Figure 3.12C).
Hotspot propensity scores of protein residues (Figure 3.12C) also showed that
bulky nonpolar amino acids dominate the residue preferences. This is also consistent with
our observations for several histone/histone-like peptide complexes (Figure 3.12D) that
bulky nonpolar residues at the binding site establish contacts with the small-volume
residues adjacent to the peptide Arg hotspot residue. Therefore, the mechanism of having
bulky residues at the L1 and L2 positions for contacting Ala and Thr of the H3 peptide
adjacent to the hotspot R2 residue is likely to be a well-tested natural mechanism, and
therefore the same strategy could be implemented in designing diagnostic proteins to
target site-specific Arg residues of histone tails. Grafting a complementary peptide
segment onto an antibody scaffold has shown promise for targeting specific peptide
segments within intrinsically disordered segments120. Our observations on nonpolar
residues could thus be useful for such a strategy for targeting intrinsically disordered
unmodified histone peptide segments.
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CHAPTER IV
GENERAL DISCUSSION AND CONCLUSION
Next-generation sequencing efforts on diagnosed patient genomes or cancer tissues
now show that aberrations (mutations or overexpression) in proteins harboring the
PHD_nW_DD subtype are associated with different pathological consequences (Figure
4.1). Therefore, as a first step toward eventual comprehension of the possible
mechanisms underlying pathological consequences, detailed characterization of the
binding mechanism of the PHD_nW_DD subtype was undertaken here. Starting with one
member (BAZ2A PHD) of the subtype, key histone peptide-anchoring residue positions
were first identified by mutagenesis. Loss of interfacial packing due to residue
substitution contributes to the observed binding energetics. Interestingly, the peptideanchoring residue positions (ΔΔG ≥ 1.0 kcal/mol) of the BAZ2A PHD are enriched in
specific types of residues in a subtype-specific manner. The energetic contributions of the
identified positions were further confirmed by mutagenesis in three other members of the
subtype (UHRF1, KDM5B, KAT6A), which included pairs sharing <40% sequence
identity with each other. Despite low sequence similarity, mutations cause similar
consequences in histone H3 binding, suggesting a strong similarity in the binding
mechanism and thus supporting the classification of the subtype.
The positions of peptide-anchoring residues of the PHD_nW_DD subtype are also
mutually correlated, while corresponding positions in artificial PHD sequences (E-value
≤ 10-5) are not. Based on our experimental observations, it is thus temping to believe that
the correlation is for biochemical function (peptide binding) rather than for folding. The
three-dimensional distances between two correlated positions in a protein sequence
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predicted by powerful computational approaches87, 88, 115, 116 can thus be complemented
by a systematic mutagenesis approach to dissect the true origin of the correlation,
particularly for positions at the functional site. Like the coevolving binding-site residues
of the versatile PDZ domain, the correlated binding-site residues of the versatile PHD
finger are also coevolving. The positions of some of the coevolving residues show very
small structural deviations among diverse sequence homologs, and this observation will
be useful for redesigning the PHD binding site for enhancing affinity and switching
specificity. The binding mechanism of the PHD_nW_DD subtype likely originated early
to anchor residues 1–3 of histone H3. This mechanism features the characteristic treble
clef knuckle Asp residues for anchoring the peptide Arg hotspot, while the acidic patch
residues contribute to the helical conformation of N-terminal histone H3. A set of
nonpolar amino acids is among the residues enriched in the PHD_nW_DD subtype, and
these nonpolar amino acids tightly pack against the peptide residues with small side
chains present on either side of the peptide hotspot Arg residue. This strategy of
employing tightly packed, bulky nonpolar residues to anchor residues with small side
chains adjacent to the peptide hotspot can be useful for histone diagnostic design. In
general, the lessons learned from the current study will be useful in the functional
characterization of large protein families.

122

Figure 4.1. Human disorders associated with PHD_nW_DD: Kebuki syndrome105-108, diffuse large B-cell
lymphoma (DLBCL)108, colorectal109, gynecological carcinoma110, intraocular medulloepitheliomas19, non–
small cell lung cancer (NSCLC)111 mutations respectively are colored in gray, pink, green, yellow, cyan,
split pea, and the upward arrow ‘↑’ indicates increase in protein expression in prostate112 and ovarian113
cancer. Protein names are on the left and star ‘*’ denotes nonsense mutations. PHRF1 is included here for
recent reports on the association of the tumor suppressor role of PHRF189, 114. All these mutations are taken
from the references cited in above, and for convenience only selected proteins and their PHD_nW_DD
mutations (among other mutations) are listed here.
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